1a327e37的个人主页 - 老虎社区

1a327e37

暂无个人介绍

IP属地：未知

123关注

11粉丝

0主题

0勋章

2022-01-17

K

US STOCKS-Dow Closes Lower after Disappointing Bank Results

2022-01-14

K

3 Meme Stocks That Are Actually Solid Long-Term Picks

2021-12-28

K

Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?

2021-12-27

K

Santa Claus Rally watch: What to know this week

2021-12-25

Ik

3 Best Buffett Stocks to Buy for the Long Haul

2021-12-24

Ok

Can Apple Stock Hit New Highs by Year's End?

2021-12-23

K

Novavax says COVID vaccine triggers immune response to Omicron variant

2021-12-20

K

3 Best Vacation Stocks To Watch In December

2021-12-19

K

5 Top-Ranked Dividend Growth Stocks for 2022

2021-12-18

K

DaVita authorizes additional $2B share repurchase

2021-12-17

K

Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron

2021-12-16

Ok

Wall St ends higher; Fed to end bond purchases in March

2021-12-15

K

Renewed Selling Pressure Likely For Singapore Stock Market

2021-12-14

Ok

These 5 stocks are driving the market

2021-12-11

Ok

抱歉，原内容已删除

2021-09-13

Ok

This Tech Stock Could Turn $10,000 Into $30,000 in 5 Years

2021-06-22

I see

抱歉，原内容已删除

2021-06-21

K

抱歉，原内容已删除

2021-06-17

K

抱歉，原内容已删除

2021-06-16

$AMOS GROUP LIMITED(RF7.SI)$k

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3586129577058331","uuid":"3586129577058331","gmtCreate":1623035694137,"gmtModify":1623036406974,"name":"1a327e37","pinyin":"1a327e37","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":11,"headSize":123,"tweetSize":39,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.18%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":697119944,"gmtCreate":1642349260169,"gmtModify":1642349260369,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697119944","repostId":"2203201745","repostType":4,"repost":{"id":"2203201745","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642201908,"share":"https://www.laohu8.com/m/news/2203201745?lang=&edition=full","pubTime":"2022-01-15 07:11","market":"us","language":"en","title":"US STOCKS-Dow Closes Lower after Disappointing Bank Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2203201745","media":"Reuters","summary":"The Dow closed lower with a big drag from financial stocks as investors were disappointed by fourth quarter results from big U.S. banks, which cast a shadow over the earnings season kick-off.The Nasda","content":"<html><head></head><body><p>The Dow closed lower with a big drag from financial stocks as investors were disappointed by fourth quarter results from big U.S. banks, which cast a shadow over the earnings season kick-off.</p><p>The Nasdaq and the S&amp;P regained lost ground in afternoon trading to close higher. Meanwhile the consumer discretionary</p><p>also put pressure on major indexes after morning data showed a December decline in retail sales and a souring of consumer sentiment.</p><p>JPMorgan Chase &amp; Co tumbled after reporting weaker performance at its trading arm. The bellwether lender also warned that soaring inflation, the looming threat of Omicron and trading revenues would challenge industry growth in coming months.</p><p>Along with JPMorgan, big decliners putting pressure on the Dow included Goldman Sachs, American Express and Home Depot.</p><p>$Citigroup Inc(C-N)$ shares fell after it reported a 26% drop in fourth-quarter profit, while asset manager BlackRock Inc</p><p>fell after missing quarterly revenue expectations.</p><p>The earnings kick-off had investors taking profits in the S&amp;P 500 bank subsector after it had hit an intraday high in the previous session. Financial stocks had been outperforming the S&amp;P recently as investors bet that the Federal Reserve&#39;s expected interest rate hikes will boost bank profits.</p><p>&#34;The bar was very high going into (JPMorgan) results. On the surface it was good but, under the hood, not so much,&#34; said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. In the interest rate hiking cycle expected this year &#34;positioning was very crowded on the long side&#34; going into the earnings season.</p><p>For consumer stock weakness, James pointed to &#34;clearly disappointing&#34; retail sales, which dropped 1.9% last month due to shortages of goods and an explosion of COVID-19 infections.</p><p>Separate data showed soaring inflation hit U.S. consumer sentiment in January, pushing it to its second lowest level in a decade.</p><p>Retail sales and bank loan growth raised doubts about the economic outlook for the current quarter and 2022 for Keith Buchanan, portfolio manager at Globalt in Atlanta.</p><p>&#34;The question is, does the economy have enough strength to get through the risk Omicron brings as fiscal and monetary stimulus is rolling off,&#34; Buchanan said.</p><p>According to preliminary data, the S&amp;P 500 gained 2.89 points, or 0.06%, to end at 4,661.92 points, while the Nasdaq Composite gained 81.98 points, or 0.55%, to 14,889.73. The Dow Jones Industrial Average fell 208.43 points, or 0.58%, to 35,905.19.</p><p>Analysts see S&amp;P 500 companies earnings rising 23.1% in the fourth quarter, according to IBES data from Refinitiv.</p><p>One bright spot in the bank sector on Friday however was Wells Fargo &amp; Co, which gained ground after posting a bigger-than-expected rise in fourth-quarter profit.</p><p>Casino operators Las Vegas Sands, Melco Resorts and Wynn Resorts rallied after Macau&#39;s government capped the number of new casino operators allowed to operate to six for a period of 10 years.</p><p>U.S. stock markets will remain shut on Monday for the public holiday in honor of Martin Luther King.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Dow Closes Lower after Disappointing Bank Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Dow Closes Lower after Disappointing Bank Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-15 07:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>The Dow closed lower with a big drag from financial stocks as investors were disappointed by fourth quarter results from big U.S. banks, which cast a shadow over the earnings season kick-off.</p><p>The Nasdaq and the S&amp;P regained lost ground in afternoon trading to close higher. Meanwhile the consumer discretionary</p><p>also put pressure on major indexes after morning data showed a December decline in retail sales and a souring of consumer sentiment.</p><p>JPMorgan Chase &amp; Co tumbled after reporting weaker performance at its trading arm. The bellwether lender also warned that soaring inflation, the looming threat of Omicron and trading revenues would challenge industry growth in coming months.</p><p>Along with JPMorgan, big decliners putting pressure on the Dow included Goldman Sachs, American Express and Home Depot.</p><p>$Citigroup Inc(C-N)$ shares fell after it reported a 26% drop in fourth-quarter profit, while asset manager BlackRock Inc</p><p>fell after missing quarterly revenue expectations.</p><p>The earnings kick-off had investors taking profits in the S&amp;P 500 bank subsector after it had hit an intraday high in the previous session. Financial stocks had been outperforming the S&amp;P recently as investors bet that the Federal Reserve&#39;s expected interest rate hikes will boost bank profits.</p><p>&#34;The bar was very high going into (JPMorgan) results. On the surface it was good but, under the hood, not so much,&#34; said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. In the interest rate hiking cycle expected this year &#34;positioning was very crowded on the long side&#34; going into the earnings season.</p><p>For consumer stock weakness, James pointed to &#34;clearly disappointing&#34; retail sales, which dropped 1.9% last month due to shortages of goods and an explosion of COVID-19 infections.</p><p>Separate data showed soaring inflation hit U.S. consumer sentiment in January, pushing it to its second lowest level in a decade.</p><p>Retail sales and bank loan growth raised doubts about the economic outlook for the current quarter and 2022 for Keith Buchanan, portfolio manager at Globalt in Atlanta.</p><p>&#34;The question is, does the economy have enough strength to get through the risk Omicron brings as fiscal and monetary stimulus is rolling off,&#34; Buchanan said.</p><p>According to preliminary data, the S&amp;P 500 gained 2.89 points, or 0.06%, to end at 4,661.92 points, while the Nasdaq Composite gained 81.98 points, or 0.55%, to 14,889.73. The Dow Jones Industrial Average fell 208.43 points, or 0.58%, to 35,905.19.</p><p>Analysts see S&amp;P 500 companies earnings rising 23.1% in the fourth quarter, according to IBES data from Refinitiv.</p><p>One bright spot in the bank sector on Friday however was Wells Fargo &amp; Co, which gained ground after posting a bigger-than-expected rise in fourth-quarter profit.</p><p>Casino operators Las Vegas Sands, Melco Resorts and Wynn Resorts rallied after Macau&#39;s government capped the number of new casino operators allowed to operate to six for a period of 10 years.</p><p>U.S. stock markets will remain shut on Monday for the public holiday in honor of Martin Luther King.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4083":"家庭装潢零售",".IXIC":"NASDAQ Composite","BK4567":"ESG概念","GS":"高盛","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓","SPY":"标普500ETF","BK4166":"消费信贷","BK4504":"桥水持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓",".SPX":"S&P 500 Index","HD":"家得宝","BK4566":"资本集团","AXP":"美国运通",".DJI":"道琼斯"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203201745","content_text":"The Dow closed lower with a big drag from financial stocks as investors were disappointed by fourth quarter results from big U.S. banks, which cast a shadow over the earnings season kick-off.The Nasdaq and the S&P regained lost ground in afternoon trading to close higher. Meanwhile the consumer discretionaryalso put pressure on major indexes after morning data showed a December decline in retail sales and a souring of consumer sentiment.JPMorgan Chase & Co tumbled after reporting weaker performance at its trading arm. The bellwether lender also warned that soaring inflation, the looming threat of Omicron and trading revenues would challenge industry growth in coming months.Along with JPMorgan, big decliners putting pressure on the Dow included Goldman Sachs, American Express and Home Depot.$Citigroup Inc(C-N)$ shares fell after it reported a 26% drop in fourth-quarter profit, while asset manager BlackRock Incfell after missing quarterly revenue expectations.The earnings kick-off had investors taking profits in the S&P 500 bank subsector after it had hit an intraday high in the previous session. Financial stocks had been outperforming the S&P recently as investors bet that the Federal Reserve's expected interest rate hikes will boost bank profits.\"The bar was very high going into (JPMorgan) results. On the surface it was good but, under the hood, not so much,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. In the interest rate hiking cycle expected this year \"positioning was very crowded on the long side\" going into the earnings season.For consumer stock weakness, James pointed to \"clearly disappointing\" retail sales, which dropped 1.9% last month due to shortages of goods and an explosion of COVID-19 infections.Separate data showed soaring inflation hit U.S. consumer sentiment in January, pushing it to its second lowest level in a decade.Retail sales and bank loan growth raised doubts about the economic outlook for the current quarter and 2022 for Keith Buchanan, portfolio manager at Globalt in Atlanta.\"The question is, does the economy have enough strength to get through the risk Omicron brings as fiscal and monetary stimulus is rolling off,\" Buchanan said.According to preliminary data, the S&P 500 gained 2.89 points, or 0.06%, to end at 4,661.92 points, while the Nasdaq Composite gained 81.98 points, or 0.55%, to 14,889.73. The Dow Jones Industrial Average fell 208.43 points, or 0.58%, to 35,905.19.Analysts see S&P 500 companies earnings rising 23.1% in the fourth quarter, according to IBES data from Refinitiv.One bright spot in the bank sector on Friday however was Wells Fargo & Co, which gained ground after posting a bigger-than-expected rise in fourth-quarter profit.Casino operators Las Vegas Sands, Melco Resorts and Wynn Resorts rallied after Macau's government capped the number of new casino operators allowed to operate to six for a period of 10 years.U.S. stock markets will remain shut on Monday for the public holiday in honor of Martin Luther King.","news_type":1},"isVote":1,"tweetType":1,"viewCount":948,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697081027,"gmtCreate":1642160906570,"gmtModify":1642160907122,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/697081027","repostId":"1144666508","repostType":4,"repost":{"id":"1144666508","kind":"news","pubTimestamp":1642160056,"share":"https://www.laohu8.com/m/news/1144666508?lang=&edition=full","pubTime":"2022-01-14 19:34","market":"us","language":"en","title":"3 Meme Stocks That Are Actually Solid Long-Term Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=1144666508","media":"Motley Fool","summary":"The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, so","content":"<html><head></head><body><p>The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, some heavily shorted and some just interesting speculative growth plays, rocketed sharply higher -- often doubling, tripling, or more in a very short time. And many took investors on quite a roller coaster ride for months.</p><p>To be sure, most meme stocks aren&#39;t worth buying as long-term investments. For example, it&#39;s tough to make a long-term investment case for <b><a href=\"https://laohu8.com/S/AMC\">AMC Entertainment</a>.</b> On the other hand, there are some stocks that got caught up in the meme stock trade that looks like solid long-term investments. And this is especially true now that there&#39;s been a massive correction in many high-growth stocks.</p><p><b>A massive opportunity and a great strategy</b></p><p><b>Offerpad</b>(NYSE:OPAD) is a real estate company that is a so-called iBuyer, or instant buyer, of homes. Offerpad&#39;s core business involves buying homes directly from sellers, doing cosmetic repairs, and then selling them directly to buyers, hopefully earning a profit in the process.</p><p>However, there are a couple of things that set Offerpad apart from its peer group (which really only consists of two other companies). For <a href=\"https://laohu8.com/S/AONE.U\">one</a> thing, Offerpad is the only iBuyer that is more focused on efficiency than all-out growth. Its unit economics have been better than those of its peers, and while it won&#39;t be consistently profitable for some time, it isn&#39;t that far from it right now.</p><p>Second, Offerpad isn&#39;t necessarily trying to completely replace open-market home sales. Its Offerpad Flex product encourages customers to list their home on the open market (with an Offerpad partner agent) and gives them a cash offer to keep in their back pocket in the event they get tired of the traditional sale process.</p><p>Offerpad went a bit meme-stockish after its late 2021 special purpose acquisition company (SPAC) merger was completed, at one point rocketing to nearly $21 from its $10 pre-SPAC valuation. Now that the SPAC boom has cooled, Offerpad has plunged to less than $6, in line with many other recent SPAC targets. But make no mistake -- this is a real business with a huge market opportunity.</p><p><b>Tons of disruptive potential</b></p><p>One of the most discussed stocks in some of the most popular trader chat rooms in 2021, <a href=\"https://laohu8.com/S/SOFI\"><b>SoFi</b></a>, went public through a Chamath Palihapitiya-backed SPAC last year (this was &#34;IPOE&#34; for those who follow Palihapitiya). It started out as a private student loan company but has since evolved into a financial ecosystem, complete with a full lineup of lending products, a credit card, a bank account, a brokerage account, and more. The company also owns the Galileo financial services API and payments platform, which provides functionality for 89 million financial accounts operated by partners.</p><p>To say SoFi&#39;s growth has been phenomenal would be an understatement. Thefintech&#39;suser base has nearly doubled over the past year to more than 2.9 million members, and these users account for roughly 4.3 million different financial products. And it&#39;s on the non-lending side of the business where the growth has been especially impressive, with a 179% year-over-year increase in products as of the third quarter of 2021.</p><p>SoFi has the capability to be a true disruptor of the traditional bank model and is making all the right moves to scale its business in a sustainable way. With shares down 36% in the last two months, now could be a great time to add it at a discount.</p><p><b>The most exciting growth is yet to come</b></p><p>Last but certainly not least, insurance disruptor <a href=\"https://laohu8.com/S/LMND\"><b>Lemonade</b></a> has been a big victim of the recent growth stock headwinds, with shares down by about 35% in the past couple of months and a total of 80% off their all-time high.</p><p>Lemonade is aninsurance technology company, aiming to provide a better way to get insurance quotes, buy policies, and submit claims. In the company&#39;s core business of renters and homeowners insurance, customer feedback has been incredibly strong.</p><p>However, it&#39;s the rollout of Lemonade Car, the company&#39;s much-anticipated auto insurance product -- along with the pending acquisition of <b>Metromile</b>(NASDAQ:MILE)-- where Lemonade could accelerate the availability of the product and rapidly scale the business. If the company can replicate its early insurance success in the auto space, and can keep loss ratios in check, Lemonade could be a big winner for patient investors.</p><p>Remember what you&#39;re buying</p><p>To be sure, these three stocks are real businesses with great long-term growth opportunities. However, it&#39;s important to keep in mind that while the &#34;meme stock&#34; craze has died down, that doesn&#39;t mean it has permanently gone away. And if it comes back, all three of these stocks are likely to experience quite a roller coaster ride. Before you add any of these to your portfolio, it&#39;s important to be prepared for that possibility.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Meme Stocks That Are Actually Solid Long-Term Picks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Meme Stocks That Are Actually Solid Long-Term Picks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-14 19:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/14/3-meme-stocks-that-are-actually-solid-long-term-pi/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, some heavily shorted and some just interesting speculative growth plays, rocketed sharply higher -- ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/14/3-meme-stocks-that-are-actually-solid-long-term-pi/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OPAD":"Offerpad Solutions","LMND":"Lemonade, Inc.","SOFI":"SoFi Technologies Inc.","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2022/01/14/3-meme-stocks-that-are-actually-solid-long-term-pi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144666508","content_text":"The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, some heavily shorted and some just interesting speculative growth plays, rocketed sharply higher -- often doubling, tripling, or more in a very short time. And many took investors on quite a roller coaster ride for months.To be sure, most meme stocks aren't worth buying as long-term investments. For example, it's tough to make a long-term investment case for AMC Entertainment. On the other hand, there are some stocks that got caught up in the meme stock trade that looks like solid long-term investments. And this is especially true now that there's been a massive correction in many high-growth stocks.A massive opportunity and a great strategyOfferpad(NYSE:OPAD) is a real estate company that is a so-called iBuyer, or instant buyer, of homes. Offerpad's core business involves buying homes directly from sellers, doing cosmetic repairs, and then selling them directly to buyers, hopefully earning a profit in the process.However, there are a couple of things that set Offerpad apart from its peer group (which really only consists of two other companies). For one thing, Offerpad is the only iBuyer that is more focused on efficiency than all-out growth. Its unit economics have been better than those of its peers, and while it won't be consistently profitable for some time, it isn't that far from it right now.Second, Offerpad isn't necessarily trying to completely replace open-market home sales. Its Offerpad Flex product encourages customers to list their home on the open market (with an Offerpad partner agent) and gives them a cash offer to keep in their back pocket in the event they get tired of the traditional sale process.Offerpad went a bit meme-stockish after its late 2021 special purpose acquisition company (SPAC) merger was completed, at one point rocketing to nearly $21 from its $10 pre-SPAC valuation. Now that the SPAC boom has cooled, Offerpad has plunged to less than $6, in line with many other recent SPAC targets. But make no mistake -- this is a real business with a huge market opportunity.Tons of disruptive potentialOne of the most discussed stocks in some of the most popular trader chat rooms in 2021, SoFi, went public through a Chamath Palihapitiya-backed SPAC last year (this was \"IPOE\" for those who follow Palihapitiya). It started out as a private student loan company but has since evolved into a financial ecosystem, complete with a full lineup of lending products, a credit card, a bank account, a brokerage account, and more. The company also owns the Galileo financial services API and payments platform, which provides functionality for 89 million financial accounts operated by partners.To say SoFi's growth has been phenomenal would be an understatement. Thefintech'suser base has nearly doubled over the past year to more than 2.9 million members, and these users account for roughly 4.3 million different financial products. And it's on the non-lending side of the business where the growth has been especially impressive, with a 179% year-over-year increase in products as of the third quarter of 2021.SoFi has the capability to be a true disruptor of the traditional bank model and is making all the right moves to scale its business in a sustainable way. With shares down 36% in the last two months, now could be a great time to add it at a discount.The most exciting growth is yet to comeLast but certainly not least, insurance disruptor Lemonade has been a big victim of the recent growth stock headwinds, with shares down by about 35% in the past couple of months and a total of 80% off their all-time high.Lemonade is aninsurance technology company, aiming to provide a better way to get insurance quotes, buy policies, and submit claims. In the company's core business of renters and homeowners insurance, customer feedback has been incredibly strong.However, it's the rollout of Lemonade Car, the company's much-anticipated auto insurance product -- along with the pending acquisition of Metromile(NASDAQ:MILE)-- where Lemonade could accelerate the availability of the product and rapidly scale the business. If the company can replicate its early insurance success in the auto space, and can keep loss ratios in check, Lemonade could be a big winner for patient investors.Remember what you're buyingTo be sure, these three stocks are real businesses with great long-term growth opportunities. However, it's important to keep in mind that while the \"meme stock\" craze has died down, that doesn't mean it has permanently gone away. And if it comes back, all three of these stocks are likely to experience quite a roller coaster ride. Before you add any of these to your portfolio, it's important to be prepared for that possibility.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1024,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696174376,"gmtCreate":1640656213980,"gmtModify":1640656703694,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696174376","repostId":"1156481741","repostType":4,"repost":{"id":"1156481741","kind":"news","pubTimestamp":1640652473,"share":"https://www.laohu8.com/m/news/1156481741?lang=&edition=full","pubTime":"2021-12-28 08:47","market":"us","language":"en","title":"Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?","url":"https://stock-news.laohu8.com/highlight/detail?id=1156481741","media":"Investors","summary":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Me","content":"<p>The Food and Drug Administration authorized&nbsp;<b>Merck</b>'s (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.</p>\n<p>The FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.<b>Pfizer</b>(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.</p>\n<p>Merck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.</p>\n<p>Merck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.</p>\n<p>Merck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.</p>\n<p>So, all in all, is Merck stock a buy or a sell right now?</p>\n<p><b>Merck Stock Fundamentals: Sales Top</b></p>\n<p>During the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.</p>\n<p>Merck also provided guidance following its&nbsp;<b>Organon</b>(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.</p>\n<p>The company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.</p>\n<p>But revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.</p>\n<p>Overall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.</p>\n<p>In the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.</p>\n<p><b>What Do Annual Metrics Say About Merck?</b></p>\n<p>As Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.</p>\n<p>Last year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.</p>\n<p>For 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.</p>\n<p>The stock ranks 6th by&nbsp;Composite Rating&nbsp;in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.</p>\n<p><b>Technical Analysis Of The Pharmaceutical Company</b></p>\n<p>Merck stock has a&nbsp;Composite Rating&nbsp;of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.</p>\n<p>Shares also have a&nbsp;Relative Strength Rating&nbsp;of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.</p>\n<p>It's also key to watch chart patterns. Merck stock broke out of a&nbsp;flat base&nbsp;with abuy point&nbsp;at 79.33 on Oct. 1, according to&nbsp;MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are&nbsp;encouraged to sell&nbsp;when a stock is 7%-8% below its entry.</p>\n<p>Merck stock also recently undercut its&nbsp;50-day&nbsp;and&nbsp;200-day&nbsp;moving averages. Both are sell signals.</p>\n<p><b>Merck Stock News: Merck Grabs Covid Deal</b></p>\n<p>Merck's molnupiravir is now authorized in the U.S., U.K. and Japan.</p>\n<p>In addition to Merck and Pfizer,<b>Atea Pharmaceuticals</b>(AVIR) and&nbsp;<b>Enanta Pharmaceuticals</b>(ENTA) working on oral Covid drugs.<b>Roche</b>(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.</p>\n<p>Analysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from&nbsp;<b>Regeneron Pharmaceuticals</b>(REGN),<b>Eli Lilly</b>(LLY) and&nbsp;<b>Vir Biotechnology</b>(VIR). Antibody drugs must be given by health care professionals.</p>\n<p>But there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.</p>\n<p>Bearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and&nbsp;<b>Gilead Sciences</b>(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.</p>\n<p>Merck also recently finished acquiring Acceleron.</p>\n<p>In early March, President Joe Biden announced Merck would help<b>Johnson &amp; Johnson</b>(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.</p>\n<p><b>Is Merck Stock A Buy Now?</b></p>\n<p>Based on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.</p>\n<p>There are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.</p>\n<p>Still, big stocks like Merck can add gains without hitting massive growth streaks.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220><strong>Investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.\nThe FDA authorized the Ridgeback Biotherapeutics-partnered pill ...</p>\n\n<a href=\"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156481741","content_text":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.\nThe FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.Pfizer(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.\nMerck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.\nMerck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.\nMerck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.\nSo, all in all, is Merck stock a buy or a sell right now?\nMerck Stock Fundamentals: Sales Top\nDuring the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.\nMerck also provided guidance following its Organon(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.\nThe company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.\nBut revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.\nOverall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.\nIn the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.\nWhat Do Annual Metrics Say About Merck?\nAs Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.\nLast year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.\nFor 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.\nThe stock ranks 6th by Composite Rating in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.\nTechnical Analysis Of The Pharmaceutical Company\nMerck stock has a Composite Rating of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.\nShares also have a Relative Strength Rating of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.\nIt's also key to watch chart patterns. Merck stock broke out of a flat base with abuy point at 79.33 on Oct. 1, according to MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are encouraged to sell when a stock is 7%-8% below its entry.\nMerck stock also recently undercut its 50-day and 200-day moving averages. Both are sell signals.\nMerck Stock News: Merck Grabs Covid Deal\nMerck's molnupiravir is now authorized in the U.S., U.K. and Japan.\nIn addition to Merck and Pfizer,Atea Pharmaceuticals(AVIR) and Enanta Pharmaceuticals(ENTA) working on oral Covid drugs.Roche(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.\nAnalysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from Regeneron Pharmaceuticals(REGN),Eli Lilly(LLY) and Vir Biotechnology(VIR). Antibody drugs must be given by health care professionals.\nBut there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.\nBearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and Gilead Sciences(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.\nMerck also recently finished acquiring Acceleron.\nIn early March, President Joe Biden announced Merck would helpJohnson & Johnson(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.\nIs Merck Stock A Buy Now?\nBased on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.\nThere are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.\nStill, big stocks like Merck can add gains without hitting massive growth streaks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1891,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696079293,"gmtCreate":1640585931325,"gmtModify":1640585931504,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696079293","repostId":"2194177239","repostType":4,"repost":{"id":"2194177239","kind":"news","pubTimestamp":1640559609,"share":"https://www.laohu8.com/m/news/2194177239?lang=&edition=full","pubTime":"2021-12-27 07:00","market":"us","language":"en","title":"Santa Claus Rally watch: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177239","media":"Yahoo Finance","summary":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.The S&P 500  is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any ","content":"<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.</p>\n<p>The S&amp;P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.</p>\n<p>The term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.</p>\n<p>According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&amp;P 500 78.9% of the time, with an average return of 1.33%.</p>\n<p>“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”</p>\n<p>And if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.</p>\n<p>\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.</p>\n<p>“Considering the bear markets of 2000 and 2008 both took place after <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"</p>\n<p>And this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.</p>\n<p>\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1279eeacff5d764e6ff5b3e8f7a24f49\" tg-width=\"4000\" tg-height=\"2667\" referrerpolicy=\"no-referrer\"><span>A man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images</span></p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday: </b>Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)</p></li>\n <li><p><b>Tuesday: </b>FHFA House Price Index, month-over-month, October (0.9% in September); S&amp;P <a href=\"https://laohu8.com/S/CLGX\">CoreLogic</a> Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&amp;P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&amp;P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)</p></li>\n <li><p><b>Wednesday: </b>Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)</p></li>\n <li><p><b>Thursday: </b>Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)</p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Wednesday: </b>FuelCell Energy Inc. (FCEL) before market open</p></li>\n <li><p><b>Thursday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Santa Claus Rally watch: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanta Claus Rally watch: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 07:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p>\n\n<a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4541":"氢能源","SPY.AU":"SPDR® S&P 500® ETF Trust","BK4096":"电气部件与设备","FCEL":"燃料电池能源"},"source_url":"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177239","content_text":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.\nThe S&P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.\nThe term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.\nAccording to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&P 500 78.9% of the time, with an average return of 1.33%.\n“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”\nAnd if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.\n\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.\n“Considering the bear markets of 2000 and 2008 both took place after one of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"\nAnd this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.\n\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"\nA man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images\nEconomic calendar\n\nMonday: Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)\nTuesday: FHFA House Price Index, month-over-month, October (0.9% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)\nWednesday: Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)\nThursday: Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)\nFriday: No notable reports scheduled for release\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: No notable reports scheduled for release\nWednesday: FuelCell Energy Inc. (FCEL) before market open\nThursday: No notable reports scheduled for release\nFriday: No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":908,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698243183,"gmtCreate":1640420556660,"gmtModify":1640420556847,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Ik","listText":"Ik","text":"Ik","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698243183","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","kind":"highlight","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMY":"施贵宝","ABBV":"艾伯维公司","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698106756,"gmtCreate":1640312839363,"gmtModify":1640313787557,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698106756","repostId":"1168865278","repostType":4,"repost":{"id":"1168865278","kind":"news","pubTimestamp":1640311666,"share":"https://www.laohu8.com/m/news/1168865278?lang=&edition=full","pubTime":"2021-12-24 10:07","market":"us","language":"en","title":"Can Apple Stock Hit New Highs by Year's End?","url":"https://stock-news.laohu8.com/highlight/detail?id=1168865278","media":"TheStreet","summary":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year","content":"<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.</p>\n<p>Apple&nbsp;shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.</p>\n<p>As the overall market continued to sway with volatility, Apple was a beacon of strength.&nbsp;We were lucky with Apple stock. In fact, incredibly lucky.</p>\n<p>On Dec. 13 the Cupertino, Calif., tech giant was&nbsp;approaching a $3 trillion valuation. But I wrote about the potential sell-the-news&nbsp;bearish reversal that was in play. The stock then posted five daily losses in a six-session span.</p>\n<p>Apple has now begun to find its footing.</p>\n<p>It was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&amp;P 500.</p>\n<p>Now bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.</p>\n<p><b>Trading Apple Stock</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6865ca6e0def05bb2a060b2af13be892\" tg-width=\"1139\" tg-height=\"866\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p>\n<p>This morning&nbsp;I had Apple on my radar. Why? It’s simple.</p>\n<p>Look at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.</p>\n<p>Rather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow&nbsp; red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.</p>\n<p>Further, Apple stock was holding the 21-day moving average.</p>\n<p>With yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.</p>\n<p>That had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.</p>\n<p>From here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.</p>\n<p>If it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.</p>\n<p>Above $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple&nbsp;finds a few upside extensions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Apple Stock Hit New Highs by Year's End?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Apple Stock Hit New Highs by Year's End?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.\nApple shares earlier this month were a market leader, but over the past few trading sessions, they...</p>\n\n<a href=\"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168865278","content_text":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year.\nApple shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.\nAs the overall market continued to sway with volatility, Apple was a beacon of strength. We were lucky with Apple stock. In fact, incredibly lucky.\nOn Dec. 13 the Cupertino, Calif., tech giant was approaching a $3 trillion valuation. But I wrote about the potential sell-the-news bearish reversal that was in play. The stock then posted five daily losses in a six-session span.\nApple has now begun to find its footing.\nIt was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&P 500.\nNow bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.\nTrading Apple Stock\nDaily chart of Apple stock.\nThis morning I had Apple on my radar. Why? It’s simple.\nLook at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.\nRather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow  red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.\nFurther, Apple stock was holding the 21-day moving average.\nWith yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.\nThat had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.\nFrom here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.\nIf it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.\nAbove $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple finds a few upside extensions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691598752,"gmtCreate":1640218291070,"gmtModify":1640218291222,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691598752","repostId":"2193511315","repostType":4,"repost":{"id":"2193511315","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640215949,"share":"https://www.laohu8.com/m/news/2193511315?lang=&edition=full","pubTime":"2021-12-23 07:32","market":"us","language":"en","title":"Novavax says COVID vaccine triggers immune response to Omicron variant","url":"https://stock-news.laohu8.com/highlight/detail?id=2193511315","media":"Reuters","summary":"Dec 22 (Reuters) - Novavax Inc's COVID-19 vaccine is effective in generating an immune response agai","content":"<p>Dec 22 (Reuters) - Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p>\n<p>Novavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization. It has previously been approved by countries including Indonesia and the Philippines but not the United States.</p>\n<p>Novavax said that receiving an additional booster dose of Novavax's vaccine further increased people's immune response to Omicron. The data was taken from Novavax's ongoing studies of its vaccine's effectiveness in adolescents and as a booster.</p>\n<p>\"We are encouraged that boosted responses against all variants were comparable to those associated with high vaccine efficacy in our Phase 3 clinical trials,” said Gregory M. Glenn, Novavax's president of research and development.</p>\n<p>Other COVID-19 vaccine manufacturers, including Pfizer Inc. and Moderna Inc., also increase immune responses to Omicron, early data from those companies has shown. Resistance in all cases is stronger in people who have received an additional booster dose.</p>\n<p>Novavax is working on developing an Omicron-specific vaccine and said Wednesday it expects to begin manufacturing doses of the variant-specific shot in January.</p>\n<p>The drugmaker will start shipping vaccines to the EU's 27 member states in January as part of its deal to supply up to 200 million doses.</p>\n<p>The company will also begin shipments in early 2022 to COVAX, a vaccine distribution mechanism overseen by WHO that allocates COVID-19 shots to poorer countries. Novavax and its partner, Serum Institute of India, have agreed to send COVAX more than 1.1 billion doses of Novavax's vaccine. </p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax says COVID vaccine triggers immune response to Omicron variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax says COVID vaccine triggers immune response to Omicron variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 07:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 22 (Reuters) - Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p>\n<p>Novavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization. It has previously been approved by countries including Indonesia and the Philippines but not the United States.</p>\n<p>Novavax said that receiving an additional booster dose of Novavax's vaccine further increased people's immune response to Omicron. The data was taken from Novavax's ongoing studies of its vaccine's effectiveness in adolescents and as a booster.</p>\n<p>\"We are encouraged that boosted responses against all variants were comparable to those associated with high vaccine efficacy in our Phase 3 clinical trials,” said Gregory M. Glenn, Novavax's president of research and development.</p>\n<p>Other COVID-19 vaccine manufacturers, including Pfizer Inc. and Moderna Inc., also increase immune responses to Omicron, early data from those companies has shown. Resistance in all cases is stronger in people who have received an additional booster dose.</p>\n<p>Novavax is working on developing an Omicron-specific vaccine and said Wednesday it expects to begin manufacturing doses of the variant-specific shot in January.</p>\n<p>The drugmaker will start shipping vaccines to the EU's 27 member states in January as part of its deal to supply up to 200 million doses.</p>\n<p>The company will also begin shipments in early 2022 to COVAX, a vaccine distribution mechanism overseen by WHO that allocates COVID-19 shots to poorer countries. Novavax and its partner, Serum Institute of India, have agreed to send COVAX more than 1.1 billion doses of Novavax's vaccine. </p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4568":"美国抗疫概念","BK4139":"生物科技"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193511315","content_text":"Dec 22 (Reuters) - Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.\nNovavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization. It has previously been approved by countries including Indonesia and the Philippines but not the United States.\nNovavax said that receiving an additional booster dose of Novavax's vaccine further increased people's immune response to Omicron. The data was taken from Novavax's ongoing studies of its vaccine's effectiveness in adolescents and as a booster.\n\"We are encouraged that boosted responses against all variants were comparable to those associated with high vaccine efficacy in our Phase 3 clinical trials,” said Gregory M. Glenn, Novavax's president of research and development.\nOther COVID-19 vaccine manufacturers, including Pfizer Inc. and Moderna Inc., also increase immune responses to Omicron, early data from those companies has shown. Resistance in all cases is stronger in people who have received an additional booster dose.\nNovavax is working on developing an Omicron-specific vaccine and said Wednesday it expects to begin manufacturing doses of the variant-specific shot in January.\nThe drugmaker will start shipping vaccines to the EU's 27 member states in January as part of its deal to supply up to 200 million doses.\nThe company will also begin shipments in early 2022 to COVAX, a vaccine distribution mechanism overseen by WHO that allocates COVID-19 shots to poorer countries. Novavax and its partner, Serum Institute of India, have agreed to send COVAX more than 1.1 billion doses of Novavax's vaccine.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693947302,"gmtCreate":1639965038003,"gmtModify":1639965417989,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693947302","repostId":"2192096049","repostType":4,"repost":{"id":"2192096049","kind":"highlight","pubTimestamp":1639963835,"share":"https://www.laohu8.com/m/news/2192096049?lang=&edition=full","pubTime":"2021-12-20 09:30","market":"us","language":"en","title":"3 Best Vacation Stocks To Watch In December","url":"https://stock-news.laohu8.com/highlight/detail?id=2192096049","media":"Motley Fool","summary":"These three stocks should be turbocharged leaders in a beaten-down sector.","content":"<p>Even after the economy reopened from the pandemic, the travel and tourism industry is still touch and go as consumers ease back into more normal routines. Any news about new coronavirus variants can send stocks skidding on fears it will derail any momentum they've built.</p>\n<p>While it's premature to give the all-clear signal, there's good reason to think 2022 and beyond will provide much better opportunities for the industry. The following trio of companies represent some of the best chances to capitalize on an industry that is still beaten down but ready to rise.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e3ea498aa9acea4ae2d9123ed790db5d\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Norwegian Cruise Lines</h2>\n<p>The cruise industry was arguably the hardest hit by the pandemic because ships were forbidden from sailing well after the rest of the economy had reopened. And when ships were allowed back to sea, it was at a greatly reduced capacity than beforehand.</p>\n<p>To survive the crisis, cruise ship operators had to take on massive amounts of debt. <b>Norwegian Cruise Line</b> (NYSE:NCLH) saw its long-term debt balloon from $6.8 billion to over $11.7 billion at the end of 2020, and its financial report last month showed it had more than $12.4 billion worth at the end of September. It recently said it was going to be adding nearly another billion dollars to the total.</p>\n<p>While it might not be smooth sailing, Norwegian is looking better than it has, even before the pandemic. Some 40% of its total capacity is back in the water, representing 11 ships across the Norwegian, Oceania, and Regent Seven Seas brands. It also notes its cumulative booked position for 2022 is in line with what it experienced in 2019, which was a record year for the cruise line. And it's achieving the elevated bookings at higher prices, even when taking into account the impact of the credits it is giving to passengers for cruises that were canceled during the pandemic.</p>\n<p>Although Norwegian's stock is down 64% from where it was before the crisis, it's more than doubled from the lows it struck in the immediate aftermath. With Wall Street expecting the cruise ship to reach parity with 2019 revenue next year and then grow 35% over the next two years, Norwegian Cruise Lines looks like a ship-shape investment.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/96a3f1a8207dea2015ed644124656e54\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Disney</h2>\n<p>Being diversified is usually a sign of strength in that it offers protection in a downturn. But it was no shield for <b>Disney</b> (NYSE:DIS), which saw virtually all of its operations impacted by the near-complete shutdown of almost all global economies.</p>\n<p>Its theme parks were closed, theaters went dark, and stores were closed, leading advertising to plummet because consumers weren't shopping. And yes, its cruise ships were forbidden to sail too.</p>\n<p>The <a href=\"https://laohu8.com/S/AONE.U\">one</a> bright spot was Disney+, the streaming service launched just prior to the pandemic, which went on to break all kinds of subscriber- number records as people forced to stay home signed up in droves.</p>\n<p>While it still labors under COVID-related restrictions that impede a full recovery, that's going to change. As the crisis recedes further in the rearview mirror, the synergies of its far-flung operations that make Disney a juggernaut will be on full display once more.</p>\n<p>Disney's theme parks are profitable once again, it's making movies once more, and its other media components are back on track. As characters inspire toys, theme park rides, and spinoff TV shows, the power of the Disney brand will return to the fore.</p>\n<p>Disney's stock is down 18% in 2021, but the revenue engines are expected to spring to life, nearly doubling to $122 billion in five years, leading profits to triple. It's a destination for investors looking to capitalize on a recovery.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/614d7000a7483cacd563eb584947ca31\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Airbnb</h2>\n<p><b>Airbnb</b> (NASDAQ:ABNB) has a simple business model of connecting people who want to get away for short-term vacations with people who have accommodations they're willing to rent out. Its stays tend to be cheaper and more convenient than those at traditional hotels, and its recent results show the pandemic did not permanently dent consumer demand for these rentals.</p>\n<p>Travel began to recover in earnest earlier this year, allowing Airbnb to post a record third quarter, with 1 billion guest arrivals worldwide. It ended 2020 with about 5.6 million listings and the number of active listings has grown every quarter this year. And there is plenty of room to grow still.</p>\n<p>While there are more than 130 million households in the U.S., there are as many as 1 billion globally, and since short-term travel accommodations in a residence is still an industry in its infancy, Airbnb has the branding to capture an even greater share of the market.</p>\n<p>And now Airbnb is getting into longer-stay rentals too, which provides a whole new avenue for growth.</p>\n<p>Analysts expect revenue to grow from $5.9 billion this year to over $13.6 billion in 2025, good for a 23% compounded annual growth rate. Although the market has priced a lot of this opportunity into the stock, shares are down 25% from their recent highs even as management expects growth to accelerate in the fourth quarter.</p>\n<p>Its asset-lite business model keeps its overhead low and profit margins high, and Airbnb is a travel-and-tourism stock investors will want to check into.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Vacation Stocks To Watch In December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Vacation Stocks To Watch In December\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 09:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/19/3-best-vacation-stocks-to-watch-in-december/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even after the economy reopened from the pandemic, the travel and tourism industry is still touch and go as consumers ease back into more normal routines. Any news about new coronavirus variants can ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/19/3-best-vacation-stocks-to-watch-in-december/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼","ABNB":"爱彼迎","NCLH":"挪威邮轮"},"source_url":"https://www.fool.com/investing/2021/12/19/3-best-vacation-stocks-to-watch-in-december/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192096049","content_text":"Even after the economy reopened from the pandemic, the travel and tourism industry is still touch and go as consumers ease back into more normal routines. Any news about new coronavirus variants can send stocks skidding on fears it will derail any momentum they've built.\nWhile it's premature to give the all-clear signal, there's good reason to think 2022 and beyond will provide much better opportunities for the industry. The following trio of companies represent some of the best chances to capitalize on an industry that is still beaten down but ready to rise.\nImage source: Getty Images.\nNorwegian Cruise Lines\nThe cruise industry was arguably the hardest hit by the pandemic because ships were forbidden from sailing well after the rest of the economy had reopened. And when ships were allowed back to sea, it was at a greatly reduced capacity than beforehand.\nTo survive the crisis, cruise ship operators had to take on massive amounts of debt. Norwegian Cruise Line (NYSE:NCLH) saw its long-term debt balloon from $6.8 billion to over $11.7 billion at the end of 2020, and its financial report last month showed it had more than $12.4 billion worth at the end of September. It recently said it was going to be adding nearly another billion dollars to the total.\nWhile it might not be smooth sailing, Norwegian is looking better than it has, even before the pandemic. Some 40% of its total capacity is back in the water, representing 11 ships across the Norwegian, Oceania, and Regent Seven Seas brands. It also notes its cumulative booked position for 2022 is in line with what it experienced in 2019, which was a record year for the cruise line. And it's achieving the elevated bookings at higher prices, even when taking into account the impact of the credits it is giving to passengers for cruises that were canceled during the pandemic.\nAlthough Norwegian's stock is down 64% from where it was before the crisis, it's more than doubled from the lows it struck in the immediate aftermath. With Wall Street expecting the cruise ship to reach parity with 2019 revenue next year and then grow 35% over the next two years, Norwegian Cruise Lines looks like a ship-shape investment.\nImage source: Getty Images.\nDisney\nBeing diversified is usually a sign of strength in that it offers protection in a downturn. But it was no shield for Disney (NYSE:DIS), which saw virtually all of its operations impacted by the near-complete shutdown of almost all global economies.\nIts theme parks were closed, theaters went dark, and stores were closed, leading advertising to plummet because consumers weren't shopping. And yes, its cruise ships were forbidden to sail too.\nThe one bright spot was Disney+, the streaming service launched just prior to the pandemic, which went on to break all kinds of subscriber- number records as people forced to stay home signed up in droves.\nWhile it still labors under COVID-related restrictions that impede a full recovery, that's going to change. As the crisis recedes further in the rearview mirror, the synergies of its far-flung operations that make Disney a juggernaut will be on full display once more.\nDisney's theme parks are profitable once again, it's making movies once more, and its other media components are back on track. As characters inspire toys, theme park rides, and spinoff TV shows, the power of the Disney brand will return to the fore.\nDisney's stock is down 18% in 2021, but the revenue engines are expected to spring to life, nearly doubling to $122 billion in five years, leading profits to triple. It's a destination for investors looking to capitalize on a recovery.\nImage source: Getty Images.\nAirbnb\nAirbnb (NASDAQ:ABNB) has a simple business model of connecting people who want to get away for short-term vacations with people who have accommodations they're willing to rent out. Its stays tend to be cheaper and more convenient than those at traditional hotels, and its recent results show the pandemic did not permanently dent consumer demand for these rentals.\nTravel began to recover in earnest earlier this year, allowing Airbnb to post a record third quarter, with 1 billion guest arrivals worldwide. It ended 2020 with about 5.6 million listings and the number of active listings has grown every quarter this year. And there is plenty of room to grow still.\nWhile there are more than 130 million households in the U.S., there are as many as 1 billion globally, and since short-term travel accommodations in a residence is still an industry in its infancy, Airbnb has the branding to capture an even greater share of the market.\nAnd now Airbnb is getting into longer-stay rentals too, which provides a whole new avenue for growth.\nAnalysts expect revenue to grow from $5.9 billion this year to over $13.6 billion in 2025, good for a 23% compounded annual growth rate. Although the market has priced a lot of this opportunity into the stock, shares are down 25% from their recent highs even as management expects growth to accelerate in the fourth quarter.\nIts asset-lite business model keeps its overhead low and profit margins high, and Airbnb is a travel-and-tourism stock investors will want to check into.","news_type":1},"isVote":1,"tweetType":1,"viewCount":966,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699757555,"gmtCreate":1639909859095,"gmtModify":1639909859267,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699757555","repostId":"2192976991","repostType":4,"repost":{"id":"2192976991","kind":"news","pubTimestamp":1639880228,"share":"https://www.laohu8.com/m/news/2192976991?lang=&edition=full","pubTime":"2021-12-19 10:17","market":"us","language":"en","title":"5 Top-Ranked Dividend Growth Stocks for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192976991","media":"Zacks","summary":"As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend","content":"<p>As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend investing seems to be a better bet. Though it does not offer dramatic price appreciation, the strategy is a major source of consistent income for investors to create wealth when returns from the equity market are at risk.</p>\n<p>Stocks with a strong history of year-over-year dividend growth form a healthy portfolio with a greater scope of capital appreciation as opposed to simple dividend-paying stocks or those that have high yields. We have selected five dividend growth stocks — <b><a href=\"https://laohu8.com/S/BCC\">Boise Cascade L.L.C.</a></b> BCC, <b>J.B. Hunt Transport Services</b> JBHT, <b>Lowe's Companies</b> LOW, <b>Broadcom Inc. </b>AVGO and <b>Carriage Services</b> CSV — that could be compelling picks for your portfolio.</p>\n<h4><b>Why Dividend Growth?</b></h4>\n<p>Stocks that have a strong history of dividend growth belong to mature companies, which are less susceptible to large swings in the market, and thus act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, these offer downside protection with their consistent increase in payouts.</p>\n<p>Additionally, these stocks have superior fundamentals that make dividend growth a quality and promising investment for the long term. These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. Further, a history of strong dividend growth indicates that dividend increase is likely in the future.</p>\n<p>Moreover, a history of dividend growth year over year leads to a healthy portfolio with a greater scope of capital appreciation than simple dividend-paying stocks or those with high yields. Although these stocks do not necessarily have the highest yields, they have outperformed for a longer period than the broader stock market or any other dividend-paying stock.</p>\n<p>As a result, picking dividend growth stocks appears as a winning strategy when some other parameters are also included.</p>\n<p><b>5-Year Historical Dividend Growth greater than zero</b>: This selects stocks with a solid dividend growth history.</p>\n<p><b>5-Year Historical Sales Growth greater than zero</b>: This represents stocks with a strong record of growing revenues.</p>\n<p><b>5-Year Historical EPS Growth greater than zero</b>: This represents stocks with a solid earnings growth history.</p>\n<p><b>Next 3-5 Year EPS Growth Rate greater than zero</b>: This represents the rate at which a company’s earnings are expected to grow. Improving earnings should help companies sustain dividend payments.</p>\n<p><b>Price/Cash Flow less than M-Industry</b>: A ratio less than M-industry indicates that the stock is undervalued in that industry and that an investor needs to pay less for better cash flow generated by the company.</p>\n<p><b>52-Week Price Change greater than S&amp;P 500 (Market Weight)</b>: This ensures that the stock appreciated more than the S&amp;P 500 over the past year.</p>\n<p><b>Top Zacks Rank</b>: Stocks having a Zacks Rank #1 (Strong Buy) and 2 (Buy) generally outperform their peers in all types of market environments.</p>\n<p><b>Growth Score of B or better</b>: Our research shows that stocks with a Growth Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.</p>\n<p>Just these few criteria narrowed down the universe from over 7,700 stocks to just 16.</p>\n<p>Here are five of the 16 stocks that fit the bill:</p>\n<p>Idaho-based <b>Boise Cascade</b> operates as a wood products manufacturer and building materials distributor. It has seen solid earnings estimate revision of 13 cents for this year over the past month and has an estimated earnings growth rate of 159%.</p>\n<p>Boise Cascade has a Zacks Rank #1 and Growth Score of A. You can see <b>the complete list of today’s Zacks #1 Rank stocks here</b>.</p>\n<p>Arkansas-based <b>J.B. Hunt Transport </b>is a provider of a broad range of transportation services to a diverse group of customers through the United States, Canada and Mexico. JBHT has an estimated earnings growth rate of 44.5% for this year and delivered an average earnings surprise of 9.89% for the past four quarters.</p>\n<p>J.B. Hunt has a Zacks Rank #2 and Growth Score of A.</p>\n<p>North Carolina-based <b>Lowe's</b> has evolved as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the world’s leading home improvement retailers offering services to homeowners, renters and commercial business customers. LOW saw solid earnings estimate revision of 54 cents over the past 30 days for the fiscal year (ending January 2022) and has an expected earnings growth rate of 34.4%.</p>\n<p>Lowe’s has a Zacks Rank #2 and Growth Score of B.</p>\n<p>California-based <b>Broadcom</b> is a premier designer, developer and global supplier of a broad range of semiconductor devices with a focus on complex digital and mixed-signal complementary metal oxide semiconductor based devices and analog III-V based products. The stock saw a solid earnings estimate revision of $2.01 for the fiscal year (ending October 2022) over the past 30 days and has an expected earnings growth rate of 17.9%.</p>\n<p>Broadcom has a Zacks Rank #2 and Growth Score of B.</p>\n<p>Texas-based <b>Carriage Services</b> is a leading provider of death care services and products in the United States. CSV delivered an average earnings surprise of 27.96% for the past four quarters and has an expected earnings growth rate of 64%.</p>\n<p>Carriage Services carries a Zacks Rank #2 and has a Growth Score of B.</p>\n<p>You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.</p>\n<p>The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top-Ranked Dividend Growth Stocks for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top-Ranked Dividend Growth Stocks for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/5-top-ranked-dividend-growth-133601757.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend investing seems to be a better bet. Though it does not offer dramatic price appreciation, the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/5-top-ranked-dividend-growth-133601757.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AVGOP":"BROADCOM INC PFD SER A 22","BCC":"Boise Cascade L.L.C.","AVGO":"博通","CSV":"Carriage Services Inc","BK4504":"桥水持仓","BK4512":"苹果概念","BK4566":"资本集团","BK4192":"特殊消费者服务","BK4515":"5G概念","JBHT":"JB Hunt运输服务","BK4083":"家庭装潢零售","LOW":"劳氏","BK4520":"美国基建股","BK4022":"陆运","BK4104":"贸易公司与经销商"},"source_url":"https://finance.yahoo.com/news/5-top-ranked-dividend-growth-133601757.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2192976991","content_text":"As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend investing seems to be a better bet. Though it does not offer dramatic price appreciation, the strategy is a major source of consistent income for investors to create wealth when returns from the equity market are at risk.\nStocks with a strong history of year-over-year dividend growth form a healthy portfolio with a greater scope of capital appreciation as opposed to simple dividend-paying stocks or those that have high yields. We have selected five dividend growth stocks — Boise Cascade L.L.C. BCC, J.B. Hunt Transport Services JBHT, Lowe's Companies LOW, Broadcom Inc. AVGO and Carriage Services CSV — that could be compelling picks for your portfolio.\nWhy Dividend Growth?\nStocks that have a strong history of dividend growth belong to mature companies, which are less susceptible to large swings in the market, and thus act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, these offer downside protection with their consistent increase in payouts.\nAdditionally, these stocks have superior fundamentals that make dividend growth a quality and promising investment for the long term. These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. Further, a history of strong dividend growth indicates that dividend increase is likely in the future.\nMoreover, a history of dividend growth year over year leads to a healthy portfolio with a greater scope of capital appreciation than simple dividend-paying stocks or those with high yields. Although these stocks do not necessarily have the highest yields, they have outperformed for a longer period than the broader stock market or any other dividend-paying stock.\nAs a result, picking dividend growth stocks appears as a winning strategy when some other parameters are also included.\n5-Year Historical Dividend Growth greater than zero: This selects stocks with a solid dividend growth history.\n5-Year Historical Sales Growth greater than zero: This represents stocks with a strong record of growing revenues.\n5-Year Historical EPS Growth greater than zero: This represents stocks with a solid earnings growth history.\nNext 3-5 Year EPS Growth Rate greater than zero: This represents the rate at which a company’s earnings are expected to grow. Improving earnings should help companies sustain dividend payments.\nPrice/Cash Flow less than M-Industry: A ratio less than M-industry indicates that the stock is undervalued in that industry and that an investor needs to pay less for better cash flow generated by the company.\n52-Week Price Change greater than S&P 500 (Market Weight): This ensures that the stock appreciated more than the S&P 500 over the past year.\nTop Zacks Rank: Stocks having a Zacks Rank #1 (Strong Buy) and 2 (Buy) generally outperform their peers in all types of market environments.\nGrowth Score of B or better: Our research shows that stocks with a Growth Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.\nJust these few criteria narrowed down the universe from over 7,700 stocks to just 16.\nHere are five of the 16 stocks that fit the bill:\nIdaho-based Boise Cascade operates as a wood products manufacturer and building materials distributor. It has seen solid earnings estimate revision of 13 cents for this year over the past month and has an estimated earnings growth rate of 159%.\nBoise Cascade has a Zacks Rank #1 and Growth Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.\nArkansas-based J.B. Hunt Transport is a provider of a broad range of transportation services to a diverse group of customers through the United States, Canada and Mexico. JBHT has an estimated earnings growth rate of 44.5% for this year and delivered an average earnings surprise of 9.89% for the past four quarters.\nJ.B. Hunt has a Zacks Rank #2 and Growth Score of A.\nNorth Carolina-based Lowe's has evolved as one of the world’s leading home improvement retailers offering services to homeowners, renters and commercial business customers. LOW saw solid earnings estimate revision of 54 cents over the past 30 days for the fiscal year (ending January 2022) and has an expected earnings growth rate of 34.4%.\nLowe’s has a Zacks Rank #2 and Growth Score of B.\nCalifornia-based Broadcom is a premier designer, developer and global supplier of a broad range of semiconductor devices with a focus on complex digital and mixed-signal complementary metal oxide semiconductor based devices and analog III-V based products. The stock saw a solid earnings estimate revision of $2.01 for the fiscal year (ending October 2022) over the past 30 days and has an expected earnings growth rate of 17.9%.\nBroadcom has a Zacks Rank #2 and Growth Score of B.\nTexas-based Carriage Services is a leading provider of death care services and products in the United States. CSV delivered an average earnings surprise of 27.96% for the past four quarters and has an expected earnings growth rate of 64%.\nCarriage Services carries a Zacks Rank #2 and has a Growth Score of B.\nYou can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.\nThe Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.","news_type":1},"isVote":1,"tweetType":1,"viewCount":922,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699518088,"gmtCreate":1639837572679,"gmtModify":1639837572876,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699518088","repostId":"1189235922","repostType":4,"repost":{"id":"1189235922","kind":"news","pubTimestamp":1639809269,"share":"https://www.laohu8.com/m/news/1189235922?lang=&edition=full","pubTime":"2021-12-18 14:34","market":"us","language":"en","title":"DaVita authorizes additional $2B share repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1189235922","media":"Seeking Alpha","summary":"DaVita  Board of Directors increased the authorization under the existing share repurchase program b","content":"<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p>\n<p>The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p>\n<p>Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DaVita authorizes additional $2B share repurchase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita authorizes additional $2B share repurchase\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 14:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DaVita  Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.\nThe amount of shares authorized to be repurchased under ...</p>\n\n<a href=\"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DVA":"达维塔保健"},"source_url":"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189235922","content_text":"DaVita  Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.\nThe amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .\nSome bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'","news_type":1},"isVote":1,"tweetType":1,"viewCount":1142,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690525322,"gmtCreate":1639695992888,"gmtModify":1639695993033,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690525322","repostId":"1108384523","repostType":4,"repost":{"id":"1108384523","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639667369,"share":"https://www.laohu8.com/m/news/1108384523?lang=&edition=full","pubTime":"2021-12-16 23:09","market":"us","language":"en","title":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=1108384523","media":"Tiger Newspress","summary":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity a","content":"<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company&nbsp;announced&nbsp;new preclinical data, published to the preprint server&nbsp;bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529).&nbsp;</p>\n<p>A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.&nbsp;</p>\n<p>Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved).&nbsp;</p>\n<p>Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with&nbsp;GlaxoSmithKline plc&nbsp;(NYSE:&nbsp;GSK), retained their in vitro neutralizing activity against omicron.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-16 23:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company&nbsp;announced&nbsp;new preclinical data, published to the preprint server&nbsp;bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529).&nbsp;</p>\n<p>A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.&nbsp;</p>\n<p>Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved).&nbsp;</p>\n<p>Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with&nbsp;GlaxoSmithKline plc&nbsp;(NYSE:&nbsp;GSK), retained their in vitro neutralizing activity against omicron.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108384523","content_text":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.The company announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529). \nA significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals. \nResearchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved). \nData demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with GlaxoSmithKline plc (NYSE: GSK), retained their in vitro neutralizing activity against omicron.","news_type":1},"isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607745114,"gmtCreate":1639609461527,"gmtModify":1639609461661,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607745114","repostId":"2191994940","repostType":4,"repost":{"id":"2191994940","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639608624,"share":"https://www.laohu8.com/m/news/2191994940?lang=&edition=full","pubTime":"2021-12-16 06:50","market":"us","language":"en","title":"Wall St ends higher; Fed to end bond purchases in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2191994940","media":"Reuters","summary":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow ","content":"<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St ends higher; Fed to end bond purchases in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St ends higher; Fed to end bond purchases in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-16 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","AAPL":"苹果","ALB":"美国雅保",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191994940","content_text":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow +1.08%, S&P 500 +1.63%, Nasdaq +2.15%\n\nDec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.\nFollowing its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.\nAll three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an upbeat tone about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.\n\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"\nThe S&P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.\nFor the session, the Dow Jones Industrial Average rose 1.08% to end at 35,927.43 points, while the S&P 500 gained 1.63% to 4,709.85.\nThe Nasdaq Composite climbed 2.15% to 15,565.58.\nVolume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.\nInflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.\n\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"\nAmong the 11 S&P 500 sector indexes, technology jumped 2.7% and healthcare rallied 2.1%.\nApple Inc climbed 2.85% and Nvidia Corp rallied 7.49%, with both lifting the S&P 500 more than any other stocks.\nThe Philadelphia Semiconductor index jumped 3.7%.\nAlbemarle Corp ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"\nAdvancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.\nThe S&P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607855252,"gmtCreate":1639527702313,"gmtModify":1639527702622,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607855252","repostId":"1197497046","repostType":4,"repost":{"id":"1197497046","kind":"news","pubTimestamp":1639526704,"share":"https://www.laohu8.com/m/news/1197497046?lang=&edition=full","pubTime":"2021-12-15 08:05","market":"sg","language":"en","title":"Renewed Selling Pressure Likely For Singapore Stock Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1197497046","media":"RTTNews","summary":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen mor","content":"<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.</p>\n<p>The global forecast for the Asian&nbsp;markets&nbsp;is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.</p>\n<p>The STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.</p>\n<p>For the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.</p>\n<p>Among the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.</p>\n<p>The lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.</p>\n<p>The Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&amp;P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.</p>\n<p>Concerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.</p>\n<p>Potentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.</p>\n<p>Lingering worries about the new Omicron variant of the&nbsp;coronavirus&nbsp;may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.</p>\n<p>Crude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.</p>\n<p>Closer to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Renewed Selling Pressure Likely For Singapore Stock Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRenewed Selling Pressure Likely For Singapore Stock Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 08:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau...</p>\n\n<a href=\"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197497046","content_text":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.\nThe global forecast for the Asian markets is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.\nThe STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.\nFor the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.\nAmong the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.\nThe lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.\nThe Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.\nConcerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.\nPotentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.\nLingering worries about the new Omicron variant of the coronavirus may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.\nCrude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.\nCloser to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.","news_type":1},"isVote":1,"tweetType":1,"viewCount":360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607004893,"gmtCreate":1639452342052,"gmtModify":1639452342206,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607004893","repostId":"1174096078","repostType":4,"repost":{"id":"1174096078","kind":"news","pubTimestamp":1639450379,"share":"https://www.laohu8.com/m/news/1174096078?lang=&edition=full","pubTime":"2021-12-14 10:52","market":"us","language":"en","title":"These 5 stocks are driving the market","url":"https://stock-news.laohu8.com/highlight/detail?id=1174096078","media":"CNN Business","summary":"London (CNN Business) - Despiteanxiety about inflationand theOmicron variant, the stock market is on","content":"<p><b>London (CNN Business)</b>&nbsp;-&nbsp;Despiteanxiety about inflationand theOmicron variant, the stock market is on track for another banner year. That's in large part thanks to stellar gains from just a handful of stocks.</p>\n<p>What's happening: According to new research from Goldman Sachs, just five companies —Microsoft,Apple,Nvidia,Tesla&nbsp;and Google parent&nbsp;Alphabet&nbsp;— have contributed 51% of S&amp;P 500 returns since April. Going back to the beginning of the year, they account for more than a third of the index's rise.</p>\n<p>We've&nbsp;spilled plenty of ink&nbsp;talking about the clout of FAANG stocks —&nbsp;Facebook, Apple,Amazon,Netflix&nbsp;and Google. But is it time to retire FAANG and ring in the era of ... MANTA?</p>\n<p><img src=\"https://static.tigerbbs.com/54f62ca486902385551327c22d6e6c76\" tg-width=\"1200\" tg-height=\"736\" width=\"100%\" height=\"auto\"></p>\n<p>After shooting up 76% in 2020, Amazon's stock is up just 6% this year, compared to a nearly 26% rise in the S&amp;P 500. Supply chain problems and pay hikes to recruit and retain workers have eaten into Amazon's profits despite the ongoing boom in online shopping.</p>\n<p>Netflix's stock has also lost steam, rising 13% this year after skyrocketing 67% in 2020. The company has scored big with shows like \"Squid Game,\" but investors are worried about whether the company can&nbsp;keep rapidly recruiting subscribers&nbsp;as competition among streaming services grows.</p>\n<p>Facebook, now called Meta, has done slightly better, jumping 21% year-to-date. But that leaves it on track for its worst year since 2018, as investors weigh regulatory threats and the social network's pivot to virtual reality.</p>\n<p>Shares in Apple and Google have popped 35% and 69%, respectively. That's good enough to join the MANTA club.</p>\n<p>Tesla also makes the cut. After rising an eye-popping 743% in 2020, shares of Elon Musk's electric carmaker have kept pushing higher. They're up 44% since the beginning of 2021 as Wall Street tries to position itself for the green energy transition.</p>\n<p>Chipmaker Nvidia, for its part, has shaken off global supply issues and matched 122% gains last year with a 131% increase in 2021. Microsoft's surging cloud business has driven a 54% stock jump this year, also beating its performance in 2020.</p>\n<p>Step back: There have been moments over the past 12 months when investors have tried to reduce their exposure to high-growth companies, which don't look as attractive in a world where interest rates could begin to rise. But on the whole, tech and Tesla have remained the&nbsp;undisputed market champions&nbsp;— even if the basket of winners looks slightly different.</p>\n<p>A question that often arises when looking at the small number of companies that power the S&amp;P 500 is whether the concentration makes the market vulnerable to a larger pullback. If something happens to Nvidia, for example, will everyone get hurt — whether they own stock in the company or not?</p>\n<p>Goldman Sachs thinks that as it stands, the risk is low. The investment bank said investors have already priced in the beginning of interest rate hikes by the Federal Reserve and notes that borrowing costs will remain extremely low. Corporate earnings also \"continue to surpass expectations.\"</p>\n<p>\"While 'unknown unknowns' cause the largest drawdowns and by their nature are impossible to assess in advance, the macro environment does not suggest drawdown risk is elevated in the coming months,\" its strategists said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 5 stocks are driving the market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 5 stocks are driving the market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 10:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/12/13/investing/premarket-stocks-trading/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>London (CNN Business) - Despiteanxiety about inflationand theOmicron variant, the stock market is on track for another banner year. That's in large part thanks to stellar gains from just a handful of ...</p>\n\n<a href=\"https://edition.cnn.com/2021/12/13/investing/premarket-stocks-trading/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软","NVDA":"英伟达","AAPL":"苹果","TSLA":"特斯拉","GOOGL":"谷歌A","NFLX":"奈飞","AMZN":"亚马逊"},"source_url":"https://edition.cnn.com/2021/12/13/investing/premarket-stocks-trading/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174096078","content_text":"London (CNN Business) - Despiteanxiety about inflationand theOmicron variant, the stock market is on track for another banner year. That's in large part thanks to stellar gains from just a handful of stocks.\nWhat's happening: According to new research from Goldman Sachs, just five companies —Microsoft,Apple,Nvidia,Tesla and Google parent Alphabet — have contributed 51% of S&P 500 returns since April. Going back to the beginning of the year, they account for more than a third of the index's rise.\nWe've spilled plenty of ink talking about the clout of FAANG stocks — Facebook, Apple,Amazon,Netflix and Google. But is it time to retire FAANG and ring in the era of ... MANTA?\n\nAfter shooting up 76% in 2020, Amazon's stock is up just 6% this year, compared to a nearly 26% rise in the S&P 500. Supply chain problems and pay hikes to recruit and retain workers have eaten into Amazon's profits despite the ongoing boom in online shopping.\nNetflix's stock has also lost steam, rising 13% this year after skyrocketing 67% in 2020. The company has scored big with shows like \"Squid Game,\" but investors are worried about whether the company can keep rapidly recruiting subscribers as competition among streaming services grows.\nFacebook, now called Meta, has done slightly better, jumping 21% year-to-date. But that leaves it on track for its worst year since 2018, as investors weigh regulatory threats and the social network's pivot to virtual reality.\nShares in Apple and Google have popped 35% and 69%, respectively. That's good enough to join the MANTA club.\nTesla also makes the cut. After rising an eye-popping 743% in 2020, shares of Elon Musk's electric carmaker have kept pushing higher. They're up 44% since the beginning of 2021 as Wall Street tries to position itself for the green energy transition.\nChipmaker Nvidia, for its part, has shaken off global supply issues and matched 122% gains last year with a 131% increase in 2021. Microsoft's surging cloud business has driven a 54% stock jump this year, also beating its performance in 2020.\nStep back: There have been moments over the past 12 months when investors have tried to reduce their exposure to high-growth companies, which don't look as attractive in a world where interest rates could begin to rise. But on the whole, tech and Tesla have remained the undisputed market champions — even if the basket of winners looks slightly different.\nA question that often arises when looking at the small number of companies that power the S&P 500 is whether the concentration makes the market vulnerable to a larger pullback. If something happens to Nvidia, for example, will everyone get hurt — whether they own stock in the company or not?\nGoldman Sachs thinks that as it stands, the risk is low. The investment bank said investors have already priced in the beginning of interest rate hikes by the Federal Reserve and notes that borrowing costs will remain extremely low. Corporate earnings also \"continue to surpass expectations.\"\n\"While 'unknown unknowns' cause the largest drawdowns and by their nature are impossible to assess in advance, the macro environment does not suggest drawdown risk is elevated in the coming months,\" its strategists said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":478,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605579897,"gmtCreate":1639199565211,"gmtModify":1639199565336,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605579897","repostId":"2190275356","repostType":4,"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":888705836,"gmtCreate":1631525217125,"gmtModify":1631891663371,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888705836","repostId":"2166303426","repostType":4,"repost":{"id":"2166303426","kind":"highlight","pubTimestamp":1631523405,"share":"https://www.laohu8.com/m/news/2166303426?lang=&edition=full","pubTime":"2021-09-13 16:56","market":"us","language":"en","title":"This Tech Stock Could Turn $10,000 Into $30,000 in 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2166303426","media":"Motley Fool","summary":"Unity powers the creation of 3D across a range of industries and use cases.","content":"<p>Since going public last September, <b>Unity Software</b> (NYSE:U) has already been a rewarding investment. Despite falling 23% from its 52-week high, the stock has still rocketed 94% higher in just under a year.</p>\n<p>Even so, now looks like a good time to add Unity to your portfolio. Its business plays into several key trends -- video games, augment and virtual reality, and artificial intelligence -- and I believe the stock price could easily triple in the next five years.</p>\n<p>Here's why.</p>\n<h2>Unity has a big market opportunity</h2>\n<p>Unity is a software company. Its platform allows clients to create, run, and monetize interactive 2D and 3D content across a range of devices, from mobile phones and gaming consoles to augmented and virtual reality headsets. For instance, game developers use the Unity engine to render characters and virtual worlds in real-time, bringing their creative visions to life.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642600%2Fgamer-2.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p>But Unity's platform has use cases in other industries as well. With its tools, architects can plan construction projects, automakers can render models of cars, and filmmakers can create and edit animated scenes. Unity's platform can also be used as a simulation engine to train artificial intelligence models, such as those used in autonomous vehicles or robots.</p>\n<p>Collectively, Unity puts its market opportunity at $33 billion by 2025, comprising $16 billion&nbsp;in the gaming industry and $17 billion&nbsp;from other use cases. However, that number should rise in the future, as technologies like the metaverse move from science fiction to reality.</p>\n<h2>Unity dominates the gaming industry</h2>\n<p>Traditionally, 3D content development has been costly and tedious. To create even the most basic interactive experiences, engineers had to invest significant time and resources to build the necessary tools. And even then, they had to recode content for each individual platform (i.e. Windows, Mac, Xbox, PlayStation).</p>\n<p>Unity solves these problems. Its real-time software allows creators to simultaneously visualize and edit content, accelerating the development workflow. And once complete, content created with Unity can be deployed across more than 20 different&nbsp;platforms without writing a single line of code. Moreover, creators can monetize their games with tools like Unity Ads and Unity IAP, which facilitate the sale of ad inventory and in-app purchases, respectively.</p>\n<p>Due to this robust value proposition, Unity has become the leading game development engine. In the fourth quarter of 2020, 71%&nbsp;of the top 1,000 mobile games were made with Unity. And 94&nbsp;of the top 100 game development studios were Unity customers.</p>\n<h2>Unity is growing quickly</h2>\n<p>Video games have become a booming industry, and mobile gaming represents the largest and fastest-growing segment in that industry. That has translated into strong demand for Unity's software tools. In fact, the company had 1.4 million&nbsp;monthly active creators on its platform last year.</p>\n<p>Unity has also seen strong demand across industries like construction, manufacturing, and entertainment, as its platform simplifies design and collaboration, replacing paper-based processes with interactive, real-time 3D content.</p>\n<p>Collectively, these growth drivers have helped Unity deliver impressive top-line results over the last two years.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2019 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$464.5 million</p></td>\n   <td width=\"156\"><p>$929.5 million</p></td>\n   <td width=\"156\"><p>41%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: Unity SEC filings, Ycharts. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Moreover, Unity's top line is accelerating. In the most recent quarter, sales surged 48% compared to the prior year, marking the 11th consecutive quarter in which the company posted top-line growth of 30% or greater.</p>\n<p>As a caveat, Unity is not profitable on a GAAP basis, and the company generated negative free cash flow of $120 million over the last 12 months. Investors should keep an eye on these metrics -- but I'm not too concerned. Unity competes in a quickly growing industry, and it makes sense to spend aggressively to capture market share. And that's exactly what management is doing.</p>\n<p>Here's the big picture: Interactive, real-time 3D content has become an important tool across numerous industries, and Unity is capitalizing on that trend. If the company can maintain its 30%-plus growth rate over the next five years, Unity's share price could easily triple by 2026 without any change in its price-to-sales ratio. That's why you should consider adding this tech stock to your portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Tech Stock Could Turn $10,000 Into $30,000 in 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Tech Stock Could Turn $10,000 Into $30,000 in 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 16:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/12/this-tech-stock-could-turn-10000-into-30000-unity/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since going public last September, Unity Software (NYSE:U) has already been a rewarding investment. Despite falling 23% from its 52-week high, the stock has still rocketed 94% higher in just under a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/12/this-tech-stock-could-turn-10000-into-30000-unity/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"U":"Unity Software Inc."},"source_url":"https://www.fool.com/investing/2021/09/12/this-tech-stock-could-turn-10000-into-30000-unity/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2166303426","content_text":"Since going public last September, Unity Software (NYSE:U) has already been a rewarding investment. Despite falling 23% from its 52-week high, the stock has still rocketed 94% higher in just under a year.\nEven so, now looks like a good time to add Unity to your portfolio. Its business plays into several key trends -- video games, augment and virtual reality, and artificial intelligence -- and I believe the stock price could easily triple in the next five years.\nHere's why.\nUnity has a big market opportunity\nUnity is a software company. Its platform allows clients to create, run, and monetize interactive 2D and 3D content across a range of devices, from mobile phones and gaming consoles to augmented and virtual reality headsets. For instance, game developers use the Unity engine to render characters and virtual worlds in real-time, bringing their creative visions to life.\nImage source: Getty Images.\nBut Unity's platform has use cases in other industries as well. With its tools, architects can plan construction projects, automakers can render models of cars, and filmmakers can create and edit animated scenes. Unity's platform can also be used as a simulation engine to train artificial intelligence models, such as those used in autonomous vehicles or robots.\nCollectively, Unity puts its market opportunity at $33 billion by 2025, comprising $16 billion in the gaming industry and $17 billion from other use cases. However, that number should rise in the future, as technologies like the metaverse move from science fiction to reality.\nUnity dominates the gaming industry\nTraditionally, 3D content development has been costly and tedious. To create even the most basic interactive experiences, engineers had to invest significant time and resources to build the necessary tools. And even then, they had to recode content for each individual platform (i.e. Windows, Mac, Xbox, PlayStation).\nUnity solves these problems. Its real-time software allows creators to simultaneously visualize and edit content, accelerating the development workflow. And once complete, content created with Unity can be deployed across more than 20 different platforms without writing a single line of code. Moreover, creators can monetize their games with tools like Unity Ads and Unity IAP, which facilitate the sale of ad inventory and in-app purchases, respectively.\nDue to this robust value proposition, Unity has become the leading game development engine. In the fourth quarter of 2020, 71% of the top 1,000 mobile games were made with Unity. And 94 of the top 100 game development studios were Unity customers.\nUnity is growing quickly\nVideo games have become a booming industry, and mobile gaming represents the largest and fastest-growing segment in that industry. That has translated into strong demand for Unity's software tools. In fact, the company had 1.4 million monthly active creators on its platform last year.\nUnity has also seen strong demand across industries like construction, manufacturing, and entertainment, as its platform simplifies design and collaboration, replacing paper-based processes with interactive, real-time 3D content.\nCollectively, these growth drivers have helped Unity deliver impressive top-line results over the last two years.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nRevenue\n$464.5 million\n$929.5 million\n41%\n\n\n\nSource: Unity SEC filings, Ycharts. TTM = trailing-12-months. CAGR = compound annual growth rate.\nMoreover, Unity's top line is accelerating. In the most recent quarter, sales surged 48% compared to the prior year, marking the 11th consecutive quarter in which the company posted top-line growth of 30% or greater.\nAs a caveat, Unity is not profitable on a GAAP basis, and the company generated negative free cash flow of $120 million over the last 12 months. Investors should keep an eye on these metrics -- but I'm not too concerned. Unity competes in a quickly growing industry, and it makes sense to spend aggressively to capture market share. And that's exactly what management is doing.\nHere's the big picture: Interactive, real-time 3D content has become an important tool across numerous industries, and Unity is capitalizing on that trend. If the company can maintain its 30%-plus growth rate over the next five years, Unity's share price could easily triple by 2026 without any change in its price-to-sales ratio. That's why you should consider adding this tech stock to your portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120413056,"gmtCreate":1624331554475,"gmtModify":1631891663369,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"I see","listText":"I see","text":"I see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120413056","repostId":"1191349655","repostType":4,"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164497234,"gmtCreate":1624232650128,"gmtModify":1631891663376,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164497234","repostId":"1154249454","repostType":4,"isVote":1,"tweetType":1,"viewCount":182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163786590,"gmtCreate":1623893613110,"gmtModify":1631891663374,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/163786590","repostId":"2143794095","repostType":4,"isVote":1,"tweetType":1,"viewCount":130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160417362,"gmtCreate":1623804223156,"gmtModify":1631888826945,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RF7.SI\">$AMOS GROUP LIMITED(RF7.SI)$</a>k","listText":"<a href=\"https://laohu8.com/S/RF7.SI\">$AMOS GROUP LIMITED(RF7.SI)$</a>k","text":"$AMOS GROUP LIMITED(RF7.SI)$k","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/160417362","isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":186193373,"gmtCreate":1623476993792,"gmtModify":1631891663386,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Help me make this become top comment please","listText":"Help me make this become top comment please","text":"Help me make this become top comment please","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":6,"commentSize":11,"repostSize":0,"link":"https://laohu8.com/post/186193373","repostId":"1104635261","repostType":4,"repost":{"id":"1104635261","kind":"news","pubTimestamp":1623470020,"share":"https://www.laohu8.com/m/news/1104635261?lang=&edition=full","pubTime":"2021-06-12 11:53","market":"us","language":"en","title":"AMC Bet by Hedge Fund Unravels Thanks to Meme-Stock Traders","url":"https://stock-news.laohu8.com/highlight/detail?id=1104635261","media":"The Wall Street Journal","summary":"Losses by Mudrick Capital show the risks of exposure to meme stocks.\n\nA multipronged bet onAMC Enter","content":"<blockquote>\n <b>Losses by Mudrick Capital show the risks of exposure to meme stocks.</b>\n</blockquote>\n<p>A multipronged bet onAMC Entertainment HoldingsInc.AMC15.39%boomeranged this month on Mudrick Capital Management LP, the latest hedge fund to fall victim to swarming day traders.</p>\n<p>Mudrick’s flagship fund lost about 10% in just a few days as a jump in AMC’s stock price unexpectedly triggered changes in the value of derivatives the fund held as part of a complex trading strategy, people familiar with the matter said.</p>\n<p>The setback comes months after a group of traders organizing on social media helped send the price ofGameStopCorp.GME5.88%and other stocks soaring in January, well beyond many investors’ views of underlying fundamentals.</p>\n<p>The development prompted many hedge funds to slash their exposure to meme stocks. Mudrick Capital’s losses highlight how risky retaining significant exposure to such companies can be—even backfiring on a hedge-fund manager who was mostly in sync with the bullishness of individual investors.</p>\n<p>Jason Mudrick, the firm’s founder, had been trading AMC stock, options and bonds for months, surfing a surge of enthusiasm for the theater chain among individual investors. But he also sold call options, derivative contracts meant to hedge the fund’s exposure to AMC should the stock price founder. Those derivative contracts, which gave its buyers the right to buy AMC stock from Mudrick at roughly $40 in the future, ballooned into liabilities when a resurgence ofReddit-fueled buyingrecently pushed AMC’s stock to new records, the people said.</p>\n<p>As part of the broader AMC strategy, executives at Mudrick Capital were in talks with AMC to buy additional shares from the company in late May. On June 1, AMC disclosed that Mudrick Capital had agreed to buy $230.5 million of new stock directly from the company at $27.12 apiece, a premium over where it was then trading.</p>\n<p>Mudrick immediately sold the stock at a profit, a quick flip that was reported by Bloomberg News and that sparked backlash on social media.</p>\n<p>“Mudrick didn’t stab AMC in the back…They shot themselves in the foot,” read one post on Reddit’s Wall Street Bets forum on June 1. Other posts around that time referenced Mudrick as “losers,” “scum bags” and “a large waving pile of s—t with no future.” Members of the forum urged each other to buy and hold.</p>\n<p>Inside Mudrick, executives were growing apprehensive as the AMC rally gained steam. The firm’s risk committee met on the evening of June 1 after the stock closed at $32 and decided to exit all debt and derivative positions the following day.</p>\n<p>It was a day too late.</p>\n<p>AMC’s stock price blew past $40in a matter of hours June 2, hitting an intraday high of $72.62.Call option prices soaredamid a frenzy of trading that Mudrick Capital contributed to and, by the end of the week, the winning trade had turned into a bust, costing the fund hundreds of millions of dollars in losses. Mudrick Capital made a roughly 5% return on the debt it sold but after accounting for its options trade, the fund took a net loss of about 5.4% on AMC.</p>\n<p>Mr. Mudrick’s fund is still up about 12% for the year, one of the people said. Meanwhile, investors who bought AMC stock at the start of the year and held on have gained about 2000%.</p>\n<p>The impact of social media-fueled day traders has become a defining market development this year, costing top hedge funds billions of dollars in losses, sparking a congressional hearing anddrawing scrutinyfrom the U.S. Securities and Exchange Commission. More hedge funds now track individual investors’ sentiment on social media and pay greater attention to companies with smaller market values whose stock price may be more susceptible to the enthusiasms of individual investors.</p>\n<p>Mr. Mudrick specializes in distressed debt investing, often lending to troubled companies at high interest rates or swapping their existing debt for equity in bankruptcy court. Mudrick manages about $3.5 billion in investments firmwide and holds large, illiquid stakes in E-cigarette maker NJOY Holdings Inc. and satellite communications companyGlobalstarInc.from such exchanges. The flagship fund reported returns of about 17% annually from 2018 to 2020, according to data from HSBC Alternative Investment Group.</p>\n<p>But distressed investing opportunities have grownharder to findas easy money from the Federal Reserve has given even struggling companies open access to debt markets. Mr. Mudrick has explored other strategies, launching several special-purpose acquisition companiesand, in the case of AMC, ultimately buying stock in block trades.</p>\n<p>Mr. Mudrick initially applied his typical playbook to AMC, buying bonds for as little as 20 cents on the dollar,lending the company $100 millionin December and swapping some bonds into new shares. Theater attendance, already under pressure, had disappeared almost entirely amid Covid-19 pandemic lockdowns, and AMC stock traded as low as $2. He reasoned that consumers would regain their appetite for big-screen entertainment this year as more Americans got vaccinated.</p>\n<p>Day traders took theirfirst run at AMC in late January, urging each other on with the social-media rallying cry of #SaveAMC and briefly lifting the stock to around $20. AMC’s rising equity value boosted debt prices—one bond Mudrick Capital owned doubled within a week—quickly rewarding Mr. Mudrick’s bullishness. AMC capitalized on its surging stock priceto raise nearly $1 billion in new financingin late January, enabling it to ward off a previously expected bankruptcy filing.</p>\n<p>Around that time, Mr. Mudrick sold call options on AMC stock, producing immediate income to offset potential losses if the theater chain did face problems. The derivatives gave buyers the option to buy AMC shares from Mudrick Capital for about $40—viewed as a seeming improbability when the stock was trading below $10.</p>\n<p>Mr. Mudrick remained in contact with AMC Chief Executive Adam Aron about providing additional funding, leading to his recent share purchase. But he kept the derivative contracts outstanding as an insurance policy, one of the people familiar with the matter said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC Bet by Hedge Fund Unravels Thanks to Meme-Stock Traders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC Bet by Hedge Fund Unravels Thanks to Meme-Stock Traders\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 11:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/amc-bet-by-hedge-fund-unravels-thanks-to-meme-stock-traders-11623431320?mod=markets_lead_pos2><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Losses by Mudrick Capital show the risks of exposure to meme stocks.\n\nA multipronged bet onAMC Entertainment HoldingsInc.AMC15.39%boomeranged this month on Mudrick Capital Management LP, the latest ...</p>\n\n<a href=\"https://www.wsj.com/articles/amc-bet-by-hedge-fund-unravels-thanks-to-meme-stock-traders-11623431320?mod=markets_lead_pos2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.wsj.com/articles/amc-bet-by-hedge-fund-unravels-thanks-to-meme-stock-traders-11623431320?mod=markets_lead_pos2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104635261","content_text":"Losses by Mudrick Capital show the risks of exposure to meme stocks.\n\nA multipronged bet onAMC Entertainment HoldingsInc.AMC15.39%boomeranged this month on Mudrick Capital Management LP, the latest hedge fund to fall victim to swarming day traders.\nMudrick’s flagship fund lost about 10% in just a few days as a jump in AMC’s stock price unexpectedly triggered changes in the value of derivatives the fund held as part of a complex trading strategy, people familiar with the matter said.\nThe setback comes months after a group of traders organizing on social media helped send the price ofGameStopCorp.GME5.88%and other stocks soaring in January, well beyond many investors’ views of underlying fundamentals.\nThe development prompted many hedge funds to slash their exposure to meme stocks. Mudrick Capital’s losses highlight how risky retaining significant exposure to such companies can be—even backfiring on a hedge-fund manager who was mostly in sync with the bullishness of individual investors.\nJason Mudrick, the firm’s founder, had been trading AMC stock, options and bonds for months, surfing a surge of enthusiasm for the theater chain among individual investors. But he also sold call options, derivative contracts meant to hedge the fund’s exposure to AMC should the stock price founder. Those derivative contracts, which gave its buyers the right to buy AMC stock from Mudrick at roughly $40 in the future, ballooned into liabilities when a resurgence ofReddit-fueled buyingrecently pushed AMC’s stock to new records, the people said.\nAs part of the broader AMC strategy, executives at Mudrick Capital were in talks with AMC to buy additional shares from the company in late May. On June 1, AMC disclosed that Mudrick Capital had agreed to buy $230.5 million of new stock directly from the company at $27.12 apiece, a premium over where it was then trading.\nMudrick immediately sold the stock at a profit, a quick flip that was reported by Bloomberg News and that sparked backlash on social media.\n“Mudrick didn’t stab AMC in the back…They shot themselves in the foot,” read one post on Reddit’s Wall Street Bets forum on June 1. Other posts around that time referenced Mudrick as “losers,” “scum bags” and “a large waving pile of s—t with no future.” Members of the forum urged each other to buy and hold.\nInside Mudrick, executives were growing apprehensive as the AMC rally gained steam. The firm’s risk committee met on the evening of June 1 after the stock closed at $32 and decided to exit all debt and derivative positions the following day.\nIt was a day too late.\nAMC’s stock price blew past $40in a matter of hours June 2, hitting an intraday high of $72.62.Call option prices soaredamid a frenzy of trading that Mudrick Capital contributed to and, by the end of the week, the winning trade had turned into a bust, costing the fund hundreds of millions of dollars in losses. Mudrick Capital made a roughly 5% return on the debt it sold but after accounting for its options trade, the fund took a net loss of about 5.4% on AMC.\nMr. Mudrick’s fund is still up about 12% for the year, one of the people said. Meanwhile, investors who bought AMC stock at the start of the year and held on have gained about 2000%.\nThe impact of social media-fueled day traders has become a defining market development this year, costing top hedge funds billions of dollars in losses, sparking a congressional hearing anddrawing scrutinyfrom the U.S. Securities and Exchange Commission. More hedge funds now track individual investors’ sentiment on social media and pay greater attention to companies with smaller market values whose stock price may be more susceptible to the enthusiasms of individual investors.\nMr. Mudrick specializes in distressed debt investing, often lending to troubled companies at high interest rates or swapping their existing debt for equity in bankruptcy court. Mudrick manages about $3.5 billion in investments firmwide and holds large, illiquid stakes in E-cigarette maker NJOY Holdings Inc. and satellite communications companyGlobalstarInc.from such exchanges. The flagship fund reported returns of about 17% annually from 2018 to 2020, according to data from HSBC Alternative Investment Group.\nBut distressed investing opportunities have grownharder to findas easy money from the Federal Reserve has given even struggling companies open access to debt markets. Mr. Mudrick has explored other strategies, launching several special-purpose acquisition companiesand, in the case of AMC, ultimately buying stock in block trades.\nMr. Mudrick initially applied his typical playbook to AMC, buying bonds for as little as 20 cents on the dollar,lending the company $100 millionin December and swapping some bonds into new shares. Theater attendance, already under pressure, had disappeared almost entirely amid Covid-19 pandemic lockdowns, and AMC stock traded as low as $2. He reasoned that consumers would regain their appetite for big-screen entertainment this year as more Americans got vaccinated.\nDay traders took theirfirst run at AMC in late January, urging each other on with the social-media rallying cry of #SaveAMC and briefly lifting the stock to around $20. AMC’s rising equity value boosted debt prices—one bond Mudrick Capital owned doubled within a week—quickly rewarding Mr. Mudrick’s bullishness. AMC capitalized on its surging stock priceto raise nearly $1 billion in new financingin late January, enabling it to ward off a previously expected bankruptcy filing.\nAround that time, Mr. Mudrick sold call options on AMC stock, producing immediate income to offset potential losses if the theater chain did face problems. The derivatives gave buyers the option to buy AMC shares from Mudrick Capital for about $40—viewed as a seeming improbability when the stock was trading below $10.\nMr. Mudrick remained in contact with AMC Chief Executive Adam Aron about providing additional funding, leading to his recent share purchase. But he kept the derivative contracts outstanding as an insurance policy, one of the people familiar with the matter said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114089567,"gmtCreate":1623035858859,"gmtModify":1634095998641,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Yeah[开心]&nbsp;","listText":"Yeah[开心]&nbsp;","text":"Yeah[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/114089567","isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607855252,"gmtCreate":1639527702313,"gmtModify":1639527702622,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607855252","repostId":"1197497046","repostType":4,"repost":{"id":"1197497046","kind":"news","pubTimestamp":1639526704,"share":"https://www.laohu8.com/m/news/1197497046?lang=&edition=full","pubTime":"2021-12-15 08:05","market":"sg","language":"en","title":"Renewed Selling Pressure Likely For Singapore Stock Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1197497046","media":"RTTNews","summary":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen mor","content":"<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.</p>\n<p>The global forecast for the Asian&nbsp;markets&nbsp;is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.</p>\n<p>The STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.</p>\n<p>For the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.</p>\n<p>Among the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.</p>\n<p>The lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.</p>\n<p>The Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&amp;P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.</p>\n<p>Concerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.</p>\n<p>Potentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.</p>\n<p>Lingering worries about the new Omicron variant of the&nbsp;coronavirus&nbsp;may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.</p>\n<p>Crude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.</p>\n<p>Closer to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Renewed Selling Pressure Likely For Singapore Stock Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRenewed Selling Pressure Likely For Singapore Stock Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 08:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau...</p>\n\n<a href=\"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197497046","content_text":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.\nThe global forecast for the Asian markets is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.\nThe STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.\nFor the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.\nAmong the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.\nThe lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.\nThe Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.\nConcerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.\nPotentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.\nLingering worries about the new Omicron variant of the coronavirus may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.\nCrude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.\nCloser to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.","news_type":1},"isVote":1,"tweetType":1,"viewCount":360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698243183,"gmtCreate":1640420556660,"gmtModify":1640420556847,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ik","listText":"Ik","text":"Ik","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698243183","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","kind":"highlight","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMY":"施贵宝","ABBV":"艾伯维公司","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":117367042,"gmtCreate":1623117770286,"gmtModify":1634036751744,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>all the way","listText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>all the way","text":"$GameStop(GME)$all the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/117367042","isVote":1,"tweetType":1,"viewCount":192,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163786590,"gmtCreate":1623893613110,"gmtModify":1631891663374,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/163786590","repostId":"2143794095","repostType":4,"repost":{"id":"2143794095","kind":"highlight","pubTimestamp":1623892525,"share":"https://www.laohu8.com/m/news/2143794095?lang=&edition=full","pubTime":"2021-06-17 09:15","market":"us","language":"en","title":"Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought","url":"https://stock-news.laohu8.com/highlight/detail?id=2143794095","media":"Motley Fool","summary":"ARK Invest's star stock picker is scooping up promising stocks that are trading well below recent highs.","content":"<p>No one consistently lit up the market the way ARK Invest's Cathie Wood did last year. The ace stock picker saw her exchange-traded funds (ETFs) soar in 2020, but her collection of disruptive growth stocks has fallen out of favor since mid-February.</p>\n<p>Wood is making the most of the correction in dynamic companies. On Tuesday she increased her positions in <b>DraftKings</b> (NASDAQ:DKNG), <b>JD.com</b> (NASDAQ:JD), and <b><a href=\"https://laohu8.com/S/PATH\">UiPath</a></b>&nbsp;(NYSE:PATH). Let's take a closer look at her shopping list.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1cff5e8a545a25eace4bc6b4d22b6ac5\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>DraftKings</h2>\n<p>Fantasy sports is a gateway drug to real-money wagering, and no <a href=\"https://laohu8.com/S/AONE.U\">one</a> is playing this game better than DraftKings. The platform that offers cash prizes for picking optimal starting league lineups is also using its popularity with competitive sports fans to prop up its growing sportsbook operations.</p>\n<p>Revenue rose 90% last year, a pretty amazing feat in a pandemic year where many seasons were delayed and shortened. Revenue soared 253% in the first quarter of this year, better-than-expected results even if the comparisons were going to be kind given the sporting world calamity that started in March of last year.</p>\n<p>DraftKings stock tumbled as much as 12% on Tuesday -- recovering to a more acceptable 4% decline by the close -- after becoming the latest short target of noted worrywart Hindenburg Research. The negative report alleges that one of the merger partners behind DraftKings hitting the market last year has a history of black-market gaming, money laundering, and organized crime. It could prove problematic if still relevant, but Wood apparently added to her DraftKings position during Tuesday's down day.</p>\n<h2>JD.com</h2>\n<p>Wood has been trimming her exposure to many of China's best-known growth stocks, but JD.com has been the exception. She has added to China's largest online retailer (in terms of revenue) on back-to-back trading days. It goes to show that investing in Chinese stocks&nbsp;isn't simply a matter of yes or no, as it's a more nuanced decision.</p>\n<p>Revenue growth decelerated to a 25% clip in 2019, but JD.com is starting to press down on the accelerator. Net revenue rose 29% last year, soaring 39% through the first three months of 2021. It's the kind of momentum you like to see in any growth stocks, and this is a good sign that -- despite unloading a lot of shares of Chinese growth stocks through May -- she's not giving up on the world's most populous nation.</p>\n<h2>UiPath</h2>\n<p>There are a couple of names scattered among Wood's ETFs that weren't even public when the year began. ARK Invest isn't afraid to buy into new issues while they still have that new stock smell, and that's where UiPath comes in. The provider of enterprise software for robotics went public at $56 just two months ago. The stock closed at $70 on Tuesday, but it was trading as high as $90 just three weeks ago. Wood doesn't let downticks sway her from investing in promising companies, and UiPath fits that bill.</p>\n<p>Revenue rose 81% in fiscal 2021, climbing 65% in the first quarter of fiscal 2022. UiPath isn't expected to turn a profit until 2024 at the earliest, but flush with nearly $1.9 billion in cash after its springtime IPO it has more than enough dry powder to stay in the fight until it gets there.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 09:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/16/cathie-wood-goes-bargain-hunting-3-stocks-she-just/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>No one consistently lit up the market the way ARK Invest's Cathie Wood did last year. The ace stock picker saw her exchange-traded funds (ETFs) soar in 2020, but her collection of disruptive growth ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/16/cathie-wood-goes-bargain-hunting-3-stocks-she-just/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JD":"京东","DKNG":"DraftKings Inc.","PATH":"UiPath"},"source_url":"https://www.fool.com/investing/2021/06/16/cathie-wood-goes-bargain-hunting-3-stocks-she-just/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143794095","content_text":"No one consistently lit up the market the way ARK Invest's Cathie Wood did last year. The ace stock picker saw her exchange-traded funds (ETFs) soar in 2020, but her collection of disruptive growth stocks has fallen out of favor since mid-February.\nWood is making the most of the correction in dynamic companies. On Tuesday she increased her positions in DraftKings (NASDAQ:DKNG), JD.com (NASDAQ:JD), and UiPath (NYSE:PATH). Let's take a closer look at her shopping list.\nImage source: Getty Images.\nDraftKings\nFantasy sports is a gateway drug to real-money wagering, and no one is playing this game better than DraftKings. The platform that offers cash prizes for picking optimal starting league lineups is also using its popularity with competitive sports fans to prop up its growing sportsbook operations.\nRevenue rose 90% last year, a pretty amazing feat in a pandemic year where many seasons were delayed and shortened. Revenue soared 253% in the first quarter of this year, better-than-expected results even if the comparisons were going to be kind given the sporting world calamity that started in March of last year.\nDraftKings stock tumbled as much as 12% on Tuesday -- recovering to a more acceptable 4% decline by the close -- after becoming the latest short target of noted worrywart Hindenburg Research. The negative report alleges that one of the merger partners behind DraftKings hitting the market last year has a history of black-market gaming, money laundering, and organized crime. It could prove problematic if still relevant, but Wood apparently added to her DraftKings position during Tuesday's down day.\nJD.com\nWood has been trimming her exposure to many of China's best-known growth stocks, but JD.com has been the exception. She has added to China's largest online retailer (in terms of revenue) on back-to-back trading days. It goes to show that investing in Chinese stocks isn't simply a matter of yes or no, as it's a more nuanced decision.\nRevenue growth decelerated to a 25% clip in 2019, but JD.com is starting to press down on the accelerator. Net revenue rose 29% last year, soaring 39% through the first three months of 2021. It's the kind of momentum you like to see in any growth stocks, and this is a good sign that -- despite unloading a lot of shares of Chinese growth stocks through May -- she's not giving up on the world's most populous nation.\nUiPath\nThere are a couple of names scattered among Wood's ETFs that weren't even public when the year began. ARK Invest isn't afraid to buy into new issues while they still have that new stock smell, and that's where UiPath comes in. The provider of enterprise software for robotics went public at $56 just two months ago. The stock closed at $70 on Tuesday, but it was trading as high as $90 just three weeks ago. Wood doesn't let downticks sway her from investing in promising companies, and UiPath fits that bill.\nRevenue rose 81% in fiscal 2021, climbing 65% in the first quarter of fiscal 2022. UiPath isn't expected to turn a profit until 2024 at the earliest, but flush with nearly $1.9 billion in cash after its springtime IPO it has more than enough dry powder to stay in the fight until it gets there.","news_type":1},"isVote":1,"tweetType":1,"viewCount":130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":696079293,"gmtCreate":1640585931325,"gmtModify":1640585931504,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696079293","repostId":"2194177239","repostType":4,"repost":{"id":"2194177239","kind":"news","pubTimestamp":1640559609,"share":"https://www.laohu8.com/m/news/2194177239?lang=&edition=full","pubTime":"2021-12-27 07:00","market":"us","language":"en","title":"Santa Claus Rally watch: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177239","media":"Yahoo Finance","summary":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.The S&P 500  is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any ","content":"<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.</p>\n<p>The S&amp;P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.</p>\n<p>The term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.</p>\n<p>According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&amp;P 500 78.9% of the time, with an average return of 1.33%.</p>\n<p>“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”</p>\n<p>And if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.</p>\n<p>\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.</p>\n<p>“Considering the bear markets of 2000 and 2008 both took place after <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"</p>\n<p>And this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.</p>\n<p>\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1279eeacff5d764e6ff5b3e8f7a24f49\" tg-width=\"4000\" tg-height=\"2667\" referrerpolicy=\"no-referrer\"><span>A man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images</span></p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday: </b>Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)</p></li>\n <li><p><b>Tuesday: </b>FHFA House Price Index, month-over-month, October (0.9% in September); S&amp;P <a href=\"https://laohu8.com/S/CLGX\">CoreLogic</a> Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&amp;P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&amp;P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)</p></li>\n <li><p><b>Wednesday: </b>Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)</p></li>\n <li><p><b>Thursday: </b>Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)</p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Wednesday: </b>FuelCell Energy Inc. (FCEL) before market open</p></li>\n <li><p><b>Thursday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Santa Claus Rally watch: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanta Claus Rally watch: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 07:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p>\n\n<a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4541":"氢能源","SPY.AU":"SPDR® S&P 500® ETF Trust","BK4096":"电气部件与设备","FCEL":"燃料电池能源"},"source_url":"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177239","content_text":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.\nThe S&P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.\nThe term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.\nAccording to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&P 500 78.9% of the time, with an average return of 1.33%.\n“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”\nAnd if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.\n\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.\n“Considering the bear markets of 2000 and 2008 both took place after one of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"\nAnd this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.\n\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"\nA man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images\nEconomic calendar\n\nMonday: Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)\nTuesday: FHFA House Price Index, month-over-month, October (0.9% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)\nWednesday: Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)\nThursday: Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)\nFriday: No notable reports scheduled for release\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: No notable reports scheduled for release\nWednesday: FuelCell Energy Inc. (FCEL) before market open\nThursday: No notable reports scheduled for release\nFriday: No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":908,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":120413056,"gmtCreate":1624331554475,"gmtModify":1631891663369,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"I see","listText":"I see","text":"I see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120413056","repostId":"1191349655","repostType":4,"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":696174376,"gmtCreate":1640656213980,"gmtModify":1640656703694,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696174376","repostId":"1156481741","repostType":4,"repost":{"id":"1156481741","kind":"news","pubTimestamp":1640652473,"share":"https://www.laohu8.com/m/news/1156481741?lang=&edition=full","pubTime":"2021-12-28 08:47","market":"us","language":"en","title":"Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?","url":"https://stock-news.laohu8.com/highlight/detail?id=1156481741","media":"Investors","summary":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Me","content":"<p>The Food and Drug Administration authorized&nbsp;<b>Merck</b>'s (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.</p>\n<p>The FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.<b>Pfizer</b>(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.</p>\n<p>Merck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.</p>\n<p>Merck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.</p>\n<p>Merck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.</p>\n<p>So, all in all, is Merck stock a buy or a sell right now?</p>\n<p><b>Merck Stock Fundamentals: Sales Top</b></p>\n<p>During the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.</p>\n<p>Merck also provided guidance following its&nbsp;<b>Organon</b>(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.</p>\n<p>The company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.</p>\n<p>But revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.</p>\n<p>Overall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.</p>\n<p>In the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.</p>\n<p><b>What Do Annual Metrics Say About Merck?</b></p>\n<p>As Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.</p>\n<p>Last year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.</p>\n<p>For 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.</p>\n<p>The stock ranks 6th by&nbsp;Composite Rating&nbsp;in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.</p>\n<p><b>Technical Analysis Of The Pharmaceutical Company</b></p>\n<p>Merck stock has a&nbsp;Composite Rating&nbsp;of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.</p>\n<p>Shares also have a&nbsp;Relative Strength Rating&nbsp;of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.</p>\n<p>It's also key to watch chart patterns. Merck stock broke out of a&nbsp;flat base&nbsp;with abuy point&nbsp;at 79.33 on Oct. 1, according to&nbsp;MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are&nbsp;encouraged to sell&nbsp;when a stock is 7%-8% below its entry.</p>\n<p>Merck stock also recently undercut its&nbsp;50-day&nbsp;and&nbsp;200-day&nbsp;moving averages. Both are sell signals.</p>\n<p><b>Merck Stock News: Merck Grabs Covid Deal</b></p>\n<p>Merck's molnupiravir is now authorized in the U.S., U.K. and Japan.</p>\n<p>In addition to Merck and Pfizer,<b>Atea Pharmaceuticals</b>(AVIR) and&nbsp;<b>Enanta Pharmaceuticals</b>(ENTA) working on oral Covid drugs.<b>Roche</b>(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.</p>\n<p>Analysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from&nbsp;<b>Regeneron Pharmaceuticals</b>(REGN),<b>Eli Lilly</b>(LLY) and&nbsp;<b>Vir Biotechnology</b>(VIR). Antibody drugs must be given by health care professionals.</p>\n<p>But there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.</p>\n<p>Bearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and&nbsp;<b>Gilead Sciences</b>(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.</p>\n<p>Merck also recently finished acquiring Acceleron.</p>\n<p>In early March, President Joe Biden announced Merck would help<b>Johnson &amp; Johnson</b>(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.</p>\n<p><b>Is Merck Stock A Buy Now?</b></p>\n<p>Based on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.</p>\n<p>There are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.</p>\n<p>Still, big stocks like Merck can add gains without hitting massive growth streaks.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220><strong>Investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.\nThe FDA authorized the Ridgeback Biotherapeutics-partnered pill ...</p>\n\n<a href=\"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156481741","content_text":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.\nThe FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.Pfizer(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.\nMerck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.\nMerck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.\nMerck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.\nSo, all in all, is Merck stock a buy or a sell right now?\nMerck Stock Fundamentals: Sales Top\nDuring the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.\nMerck also provided guidance following its Organon(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.\nThe company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.\nBut revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.\nOverall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.\nIn the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.\nWhat Do Annual Metrics Say About Merck?\nAs Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.\nLast year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.\nFor 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.\nThe stock ranks 6th by Composite Rating in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.\nTechnical Analysis Of The Pharmaceutical Company\nMerck stock has a Composite Rating of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.\nShares also have a Relative Strength Rating of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.\nIt's also key to watch chart patterns. Merck stock broke out of a flat base with abuy point at 79.33 on Oct. 1, according to MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are encouraged to sell when a stock is 7%-8% below its entry.\nMerck stock also recently undercut its 50-day and 200-day moving averages. Both are sell signals.\nMerck Stock News: Merck Grabs Covid Deal\nMerck's molnupiravir is now authorized in the U.S., U.K. and Japan.\nIn addition to Merck and Pfizer,Atea Pharmaceuticals(AVIR) and Enanta Pharmaceuticals(ENTA) working on oral Covid drugs.Roche(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.\nAnalysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from Regeneron Pharmaceuticals(REGN),Eli Lilly(LLY) and Vir Biotechnology(VIR). Antibody drugs must be given by health care professionals.\nBut there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.\nBearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and Gilead Sciences(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.\nMerck also recently finished acquiring Acceleron.\nIn early March, President Joe Biden announced Merck would helpJohnson & Johnson(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.\nIs Merck Stock A Buy Now?\nBased on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.\nThere are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.\nStill, big stocks like Merck can add gains without hitting massive growth streaks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1891,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698106756,"gmtCreate":1640312839363,"gmtModify":1640313787557,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698106756","repostId":"1168865278","repostType":4,"repost":{"id":"1168865278","kind":"news","pubTimestamp":1640311666,"share":"https://www.laohu8.com/m/news/1168865278?lang=&edition=full","pubTime":"2021-12-24 10:07","market":"us","language":"en","title":"Can Apple Stock Hit New Highs by Year's End?","url":"https://stock-news.laohu8.com/highlight/detail?id=1168865278","media":"TheStreet","summary":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year","content":"<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.</p>\n<p>Apple&nbsp;shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.</p>\n<p>As the overall market continued to sway with volatility, Apple was a beacon of strength.&nbsp;We were lucky with Apple stock. In fact, incredibly lucky.</p>\n<p>On Dec. 13 the Cupertino, Calif., tech giant was&nbsp;approaching a $3 trillion valuation. But I wrote about the potential sell-the-news&nbsp;bearish reversal that was in play. The stock then posted five daily losses in a six-session span.</p>\n<p>Apple has now begun to find its footing.</p>\n<p>It was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&amp;P 500.</p>\n<p>Now bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.</p>\n<p><b>Trading Apple Stock</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6865ca6e0def05bb2a060b2af13be892\" tg-width=\"1139\" tg-height=\"866\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p>\n<p>This morning&nbsp;I had Apple on my radar. Why? It’s simple.</p>\n<p>Look at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.</p>\n<p>Rather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow&nbsp; red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.</p>\n<p>Further, Apple stock was holding the 21-day moving average.</p>\n<p>With yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.</p>\n<p>That had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.</p>\n<p>From here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.</p>\n<p>If it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.</p>\n<p>Above $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple&nbsp;finds a few upside extensions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Apple Stock Hit New Highs by Year's End?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Apple Stock Hit New Highs by Year's End?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.\nApple shares earlier this month were a market leader, but over the past few trading sessions, they...</p>\n\n<a href=\"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168865278","content_text":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year.\nApple shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.\nAs the overall market continued to sway with volatility, Apple was a beacon of strength. We were lucky with Apple stock. In fact, incredibly lucky.\nOn Dec. 13 the Cupertino, Calif., tech giant was approaching a $3 trillion valuation. But I wrote about the potential sell-the-news bearish reversal that was in play. The stock then posted five daily losses in a six-session span.\nApple has now begun to find its footing.\nIt was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&P 500.\nNow bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.\nTrading Apple Stock\nDaily chart of Apple stock.\nThis morning I had Apple on my radar. Why? It’s simple.\nLook at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.\nRather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow  red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.\nFurther, Apple stock was holding the 21-day moving average.\nWith yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.\nThat had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.\nFrom here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.\nIf it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.\nAbove $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple finds a few upside extensions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607745114,"gmtCreate":1639609461527,"gmtModify":1639609461661,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607745114","repostId":"2191994940","repostType":4,"repost":{"id":"2191994940","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639608624,"share":"https://www.laohu8.com/m/news/2191994940?lang=&edition=full","pubTime":"2021-12-16 06:50","market":"us","language":"en","title":"Wall St ends higher; Fed to end bond purchases in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2191994940","media":"Reuters","summary":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow ","content":"<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St ends higher; Fed to end bond purchases in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St ends higher; Fed to end bond purchases in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-16 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","AAPL":"苹果","ALB":"美国雅保",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191994940","content_text":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow +1.08%, S&P 500 +1.63%, Nasdaq +2.15%\n\nDec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.\nFollowing its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.\nAll three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an upbeat tone about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.\n\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"\nThe S&P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.\nFor the session, the Dow Jones Industrial Average rose 1.08% to end at 35,927.43 points, while the S&P 500 gained 1.63% to 4,709.85.\nThe Nasdaq Composite climbed 2.15% to 15,565.58.\nVolume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.\nInflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.\n\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"\nAmong the 11 S&P 500 sector indexes, technology jumped 2.7% and healthcare rallied 2.1%.\nApple Inc climbed 2.85% and Nvidia Corp rallied 7.49%, with both lifting the S&P 500 more than any other stocks.\nThe Philadelphia Semiconductor index jumped 3.7%.\nAlbemarle Corp ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"\nAdvancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.\nThe S&P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":888705836,"gmtCreate":1631525217125,"gmtModify":1631891663371,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888705836","repostId":"2166303426","repostType":4,"repost":{"id":"2166303426","kind":"highlight","pubTimestamp":1631523405,"share":"https://www.laohu8.com/m/news/2166303426?lang=&edition=full","pubTime":"2021-09-13 16:56","market":"us","language":"en","title":"This Tech Stock Could Turn $10,000 Into $30,000 in 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2166303426","media":"Motley Fool","summary":"Unity powers the creation of 3D across a range of industries and use cases.","content":"<p>Since going public last September, <b>Unity Software</b> (NYSE:U) has already been a rewarding investment. Despite falling 23% from its 52-week high, the stock has still rocketed 94% higher in just under a year.</p>\n<p>Even so, now looks like a good time to add Unity to your portfolio. Its business plays into several key trends -- video games, augment and virtual reality, and artificial intelligence -- and I believe the stock price could easily triple in the next five years.</p>\n<p>Here's why.</p>\n<h2>Unity has a big market opportunity</h2>\n<p>Unity is a software company. Its platform allows clients to create, run, and monetize interactive 2D and 3D content across a range of devices, from mobile phones and gaming consoles to augmented and virtual reality headsets. For instance, game developers use the Unity engine to render characters and virtual worlds in real-time, bringing their creative visions to life.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642600%2Fgamer-2.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p>But Unity's platform has use cases in other industries as well. With its tools, architects can plan construction projects, automakers can render models of cars, and filmmakers can create and edit animated scenes. Unity's platform can also be used as a simulation engine to train artificial intelligence models, such as those used in autonomous vehicles or robots.</p>\n<p>Collectively, Unity puts its market opportunity at $33 billion by 2025, comprising $16 billion&nbsp;in the gaming industry and $17 billion&nbsp;from other use cases. However, that number should rise in the future, as technologies like the metaverse move from science fiction to reality.</p>\n<h2>Unity dominates the gaming industry</h2>\n<p>Traditionally, 3D content development has been costly and tedious. To create even the most basic interactive experiences, engineers had to invest significant time and resources to build the necessary tools. And even then, they had to recode content for each individual platform (i.e. Windows, Mac, Xbox, PlayStation).</p>\n<p>Unity solves these problems. Its real-time software allows creators to simultaneously visualize and edit content, accelerating the development workflow. And once complete, content created with Unity can be deployed across more than 20 different&nbsp;platforms without writing a single line of code. Moreover, creators can monetize their games with tools like Unity Ads and Unity IAP, which facilitate the sale of ad inventory and in-app purchases, respectively.</p>\n<p>Due to this robust value proposition, Unity has become the leading game development engine. In the fourth quarter of 2020, 71%&nbsp;of the top 1,000 mobile games were made with Unity. And 94&nbsp;of the top 100 game development studios were Unity customers.</p>\n<h2>Unity is growing quickly</h2>\n<p>Video games have become a booming industry, and mobile gaming represents the largest and fastest-growing segment in that industry. That has translated into strong demand for Unity's software tools. In fact, the company had 1.4 million&nbsp;monthly active creators on its platform last year.</p>\n<p>Unity has also seen strong demand across industries like construction, manufacturing, and entertainment, as its platform simplifies design and collaboration, replacing paper-based processes with interactive, real-time 3D content.</p>\n<p>Collectively, these growth drivers have helped Unity deliver impressive top-line results over the last two years.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2019 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$464.5 million</p></td>\n   <td width=\"156\"><p>$929.5 million</p></td>\n   <td width=\"156\"><p>41%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: Unity SEC filings, Ycharts. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Moreover, Unity's top line is accelerating. In the most recent quarter, sales surged 48% compared to the prior year, marking the 11th consecutive quarter in which the company posted top-line growth of 30% or greater.</p>\n<p>As a caveat, Unity is not profitable on a GAAP basis, and the company generated negative free cash flow of $120 million over the last 12 months. Investors should keep an eye on these metrics -- but I'm not too concerned. Unity competes in a quickly growing industry, and it makes sense to spend aggressively to capture market share. And that's exactly what management is doing.</p>\n<p>Here's the big picture: Interactive, real-time 3D content has become an important tool across numerous industries, and Unity is capitalizing on that trend. If the company can maintain its 30%-plus growth rate over the next five years, Unity's share price could easily triple by 2026 without any change in its price-to-sales ratio. That's why you should consider adding this tech stock to your portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Tech Stock Could Turn $10,000 Into $30,000 in 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Tech Stock Could Turn $10,000 Into $30,000 in 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 16:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/12/this-tech-stock-could-turn-10000-into-30000-unity/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since going public last September, Unity Software (NYSE:U) has already been a rewarding investment. Despite falling 23% from its 52-week high, the stock has still rocketed 94% higher in just under a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/12/this-tech-stock-could-turn-10000-into-30000-unity/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"U":"Unity Software Inc."},"source_url":"https://www.fool.com/investing/2021/09/12/this-tech-stock-could-turn-10000-into-30000-unity/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2166303426","content_text":"Since going public last September, Unity Software (NYSE:U) has already been a rewarding investment. Despite falling 23% from its 52-week high, the stock has still rocketed 94% higher in just under a year.\nEven so, now looks like a good time to add Unity to your portfolio. Its business plays into several key trends -- video games, augment and virtual reality, and artificial intelligence -- and I believe the stock price could easily triple in the next five years.\nHere's why.\nUnity has a big market opportunity\nUnity is a software company. Its platform allows clients to create, run, and monetize interactive 2D and 3D content across a range of devices, from mobile phones and gaming consoles to augmented and virtual reality headsets. For instance, game developers use the Unity engine to render characters and virtual worlds in real-time, bringing their creative visions to life.\nImage source: Getty Images.\nBut Unity's platform has use cases in other industries as well. With its tools, architects can plan construction projects, automakers can render models of cars, and filmmakers can create and edit animated scenes. Unity's platform can also be used as a simulation engine to train artificial intelligence models, such as those used in autonomous vehicles or robots.\nCollectively, Unity puts its market opportunity at $33 billion by 2025, comprising $16 billion in the gaming industry and $17 billion from other use cases. However, that number should rise in the future, as technologies like the metaverse move from science fiction to reality.\nUnity dominates the gaming industry\nTraditionally, 3D content development has been costly and tedious. To create even the most basic interactive experiences, engineers had to invest significant time and resources to build the necessary tools. And even then, they had to recode content for each individual platform (i.e. Windows, Mac, Xbox, PlayStation).\nUnity solves these problems. Its real-time software allows creators to simultaneously visualize and edit content, accelerating the development workflow. And once complete, content created with Unity can be deployed across more than 20 different platforms without writing a single line of code. Moreover, creators can monetize their games with tools like Unity Ads and Unity IAP, which facilitate the sale of ad inventory and in-app purchases, respectively.\nDue to this robust value proposition, Unity has become the leading game development engine. In the fourth quarter of 2020, 71% of the top 1,000 mobile games were made with Unity. And 94 of the top 100 game development studios were Unity customers.\nUnity is growing quickly\nVideo games have become a booming industry, and mobile gaming represents the largest and fastest-growing segment in that industry. That has translated into strong demand for Unity's software tools. In fact, the company had 1.4 million monthly active creators on its platform last year.\nUnity has also seen strong demand across industries like construction, manufacturing, and entertainment, as its platform simplifies design and collaboration, replacing paper-based processes with interactive, real-time 3D content.\nCollectively, these growth drivers have helped Unity deliver impressive top-line results over the last two years.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nRevenue\n$464.5 million\n$929.5 million\n41%\n\n\n\nSource: Unity SEC filings, Ycharts. TTM = trailing-12-months. CAGR = compound annual growth rate.\nMoreover, Unity's top line is accelerating. In the most recent quarter, sales surged 48% compared to the prior year, marking the 11th consecutive quarter in which the company posted top-line growth of 30% or greater.\nAs a caveat, Unity is not profitable on a GAAP basis, and the company generated negative free cash flow of $120 million over the last 12 months. Investors should keep an eye on these metrics -- but I'm not too concerned. Unity competes in a quickly growing industry, and it makes sense to spend aggressively to capture market share. And that's exactly what management is doing.\nHere's the big picture: Interactive, real-time 3D content has become an important tool across numerous industries, and Unity is capitalizing on that trend. If the company can maintain its 30%-plus growth rate over the next five years, Unity's share price could easily triple by 2026 without any change in its price-to-sales ratio. That's why you should consider adding this tech stock to your portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186902286,"gmtCreate":1623467799845,"gmtModify":1631889071152,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>yee","listText":"<a href=\"https://laohu8.com/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>yee","text":"$STARHILL GLOBAL REIT(P40U.SI)$yee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/186902286","isVote":1,"tweetType":1,"viewCount":207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114088233,"gmtCreate":1623036083222,"gmtModify":1634095996521,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Yeah","listText":"Yeah","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/114088233","repostId":"2141299286","repostType":4,"repost":{"id":"2141299286","kind":"highlight","pubTimestamp":1623035520,"share":"https://www.laohu8.com/m/news/2141299286?lang=&edition=full","pubTime":"2021-06-07 11:12","market":"us","language":"en","title":"Is Now the Time to Sell AMC Entertainment Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2141299286","media":"Motley Fool","summary":"The movie theater operator has the potential to make an impressive comeback -- but not for the reason you might think.","content":"<p>Over the past year, the iconic theater chain <b>AMC Entertainment Holdings </b>(NYSE:AMC) has won over the hearts and souls of WallStreetBets traders. On last&nbsp;Wednesday, its shares skyrocketed another 95.6% after the company announced it would launch an exclusive web platform for retail investors. Shareholders would receive many perks, including free popcorn, exclusive new screenings, and the chance to speak with CEO Adam Aron.</p><p>Enthusiasm about AMC's turnaround prospects have sent its shares soaring more than 400% in the past month and 2,100% year to date. Is the stock a safe investment right now?</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F629366%2Fgettyimages-104187332.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p><h2>What's behind the hype?</h2><p>During the first quarter of 2021, AMC operated 585 of its domestic theaters at just 15% to 60% capacity, while only 27% of its 133 international ones stayed partly open. People steered clear of packed indoor movie screenings with the coronavirus pandemic still going strong, but that's less of a risk as more of the U.S. population has been vaccinated.</p><p>Hence, investors are betting that AMC's revenue and earnings will experience a massive rebound starting in the second quarter. In 2019, the company generated $5.42 billion from ticket, concessions (food and beverage), and entertainment sales and posted a free cash flow of $84 million.</p><p>But there's more. The pandemic also led to extended production delays, as social distancing can be difficult on a movie set. Many producers also did not want to release completed films in a purely digital format and miss out on lucrative box office revenue.&nbsp;</p><p>There is now a massive backlog of new films from blockbuster franchise properties such as <i>Avatar</i>,&nbsp;<i>Dungeons &amp; Dragons, Ghostbusters, Halloween, Kingsman, The Matrix, Minecraft, Mission: Impossible, </i>and<i> Tomb Raider, </i>as well as several new offerings from the comic book universes of DC and Marvel. They are all scheduled to be released by the end of 2022.</p><p>The schedule is so packed that prominent films like&nbsp;<i>Black Widow</i>&nbsp;and&nbsp;<i>Cinderella&nbsp;</i>are set to hit theaters within two weeks of <a href=\"https://laohu8.com/S/AONE\">one</a> another in July. Given its sheer size, AMC might even see its box office revenue hit record highs in 2022.</p><h2>Can you count on AMC?</h2><p>Generally speaking, most investors tend to buy on emotion and justify with reason. Now is probably time to look at the latter. When the stock was trading for just $12 last month, it looked pretty undervalued.</p><p>However, things have changed as AMC's market cap has surged to nearly $25 billion. To put things into perspective, the company's market cap was less than <a href=\"https://laohu8.com/S/AONE.U\">one</a>-fifth of that amount in 2016, before streaming services like <b>Netflix</b>&nbsp;gained momentum and took away some of its market share.&nbsp;</p><p>What's more, AMC has $5.4 billion in long-term debt and owes $4.9 billion per year in theater rent. Even in its heyday, the company operated at razor-thin margins. Now its balance sheet looks even worse as liabilities outpace its assets by over $2 billion. For these reasons, it's probably a good time to take profits on the stock and consolidate gains.</p><h2>But watch for its next move</h2><p>Based on the poor fundamentals (and experience with market bubbles), it can be very tempting to see the recent rally as nothing more than a pump-and-dump scheme or a total scam. But there is something that even prudent investors are missing.&nbsp;</p><p>With a $25 billion market cap, AMC only has to issue 22% more shares to raise cash to pay off its entire debt balance. That's right: The company has the potential to do a \"soft reset\" and start afresh. The returns would be immediate, as after closing, it would no longer have to pay $151.5 million per quarter in interest. In the first quarter of 2021, the company's interest expense outweighed its total revenue.</p><p>Not only would its profit margins increase, but it could also use new cash to increase its theater count, upgrade its recliner seats and big screens, introduce dine-in restaurants at its locations, and more. Since there is still a lot of demand from retail investors at these levels, I don't think it would have trouble finding buyers for the offering, either.</p><p>In fact, the company did just that on June 3. AMC sold 11.5 million shares of stock hours after announcing the offering, raising $587.4 million in much-needed cash. The stock fell by more than 30% from the previous day's close before recovering. Investors should continue to expect further dilutions ahead, as the new capital is still not enough for a soft reset of its liabilities.</p><p>Overall, AMC stock is very overvalued at these levels. But thanks to the help of 10.3 million traders/followers/influencers of WallStreetBets, the company now has the option to refinance or eliminate its crippling liabilities. If the share price comes down to something more reasonable (say, $20), I'd definitely give the new AMC a chance. For now, check out these alternatives instead.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Now the Time to Sell AMC Entertainment Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Now the Time to Sell AMC Entertainment Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 11:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/06/is-now-the-time-to-sell-amc-entertainment-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past year, the iconic theater chain AMC Entertainment Holdings (NYSE:AMC) has won over the hearts and souls of WallStreetBets traders. On last Wednesday, its shares skyrocketed another 95.6% ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/06/is-now-the-time-to-sell-amc-entertainment-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TIME":"Clockwise Core Equity & Innovation ETF","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/06/06/is-now-the-time-to-sell-amc-entertainment-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2141299286","content_text":"Over the past year, the iconic theater chain AMC Entertainment Holdings (NYSE:AMC) has won over the hearts and souls of WallStreetBets traders. On last Wednesday, its shares skyrocketed another 95.6% after the company announced it would launch an exclusive web platform for retail investors. Shareholders would receive many perks, including free popcorn, exclusive new screenings, and the chance to speak with CEO Adam Aron.Enthusiasm about AMC's turnaround prospects have sent its shares soaring more than 400% in the past month and 2,100% year to date. Is the stock a safe investment right now?Image source: Getty Images.What's behind the hype?During the first quarter of 2021, AMC operated 585 of its domestic theaters at just 15% to 60% capacity, while only 27% of its 133 international ones stayed partly open. People steered clear of packed indoor movie screenings with the coronavirus pandemic still going strong, but that's less of a risk as more of the U.S. population has been vaccinated.Hence, investors are betting that AMC's revenue and earnings will experience a massive rebound starting in the second quarter. In 2019, the company generated $5.42 billion from ticket, concessions (food and beverage), and entertainment sales and posted a free cash flow of $84 million.But there's more. The pandemic also led to extended production delays, as social distancing can be difficult on a movie set. Many producers also did not want to release completed films in a purely digital format and miss out on lucrative box office revenue. There is now a massive backlog of new films from blockbuster franchise properties such as Avatar, Dungeons & Dragons, Ghostbusters, Halloween, Kingsman, The Matrix, Minecraft, Mission: Impossible, and Tomb Raider, as well as several new offerings from the comic book universes of DC and Marvel. They are all scheduled to be released by the end of 2022.The schedule is so packed that prominent films like Black Widow and Cinderella are set to hit theaters within two weeks of one another in July. Given its sheer size, AMC might even see its box office revenue hit record highs in 2022.Can you count on AMC?Generally speaking, most investors tend to buy on emotion and justify with reason. Now is probably time to look at the latter. When the stock was trading for just $12 last month, it looked pretty undervalued.However, things have changed as AMC's market cap has surged to nearly $25 billion. To put things into perspective, the company's market cap was less than one-fifth of that amount in 2016, before streaming services like Netflix gained momentum and took away some of its market share. What's more, AMC has $5.4 billion in long-term debt and owes $4.9 billion per year in theater rent. Even in its heyday, the company operated at razor-thin margins. Now its balance sheet looks even worse as liabilities outpace its assets by over $2 billion. For these reasons, it's probably a good time to take profits on the stock and consolidate gains.But watch for its next moveBased on the poor fundamentals (and experience with market bubbles), it can be very tempting to see the recent rally as nothing more than a pump-and-dump scheme or a total scam. But there is something that even prudent investors are missing. With a $25 billion market cap, AMC only has to issue 22% more shares to raise cash to pay off its entire debt balance. That's right: The company has the potential to do a \"soft reset\" and start afresh. The returns would be immediate, as after closing, it would no longer have to pay $151.5 million per quarter in interest. In the first quarter of 2021, the company's interest expense outweighed its total revenue.Not only would its profit margins increase, but it could also use new cash to increase its theater count, upgrade its recliner seats and big screens, introduce dine-in restaurants at its locations, and more. Since there is still a lot of demand from retail investors at these levels, I don't think it would have trouble finding buyers for the offering, either.In fact, the company did just that on June 3. AMC sold 11.5 million shares of stock hours after announcing the offering, raising $587.4 million in much-needed cash. The stock fell by more than 30% from the previous day's close before recovering. Investors should continue to expect further dilutions ahead, as the new capital is still not enough for a soft reset of its liabilities.Overall, AMC stock is very overvalued at these levels. But thanks to the help of 10.3 million traders/followers/influencers of WallStreetBets, the company now has the option to refinance or eliminate its crippling liabilities. If the share price comes down to something more reasonable (say, $20), I'd definitely give the new AMC a chance. For now, check out these alternatives instead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":697081027,"gmtCreate":1642160906570,"gmtModify":1642160907122,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/697081027","repostId":"1144666508","repostType":4,"repost":{"id":"1144666508","kind":"news","pubTimestamp":1642160056,"share":"https://www.laohu8.com/m/news/1144666508?lang=&edition=full","pubTime":"2022-01-14 19:34","market":"us","language":"en","title":"3 Meme Stocks That Are Actually Solid Long-Term Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=1144666508","media":"Motley Fool","summary":"The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, so","content":"<html><head></head><body><p>The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, some heavily shorted and some just interesting speculative growth plays, rocketed sharply higher -- often doubling, tripling, or more in a very short time. And many took investors on quite a roller coaster ride for months.</p><p>To be sure, most meme stocks aren&#39;t worth buying as long-term investments. For example, it&#39;s tough to make a long-term investment case for <b><a href=\"https://laohu8.com/S/AMC\">AMC Entertainment</a>.</b> On the other hand, there are some stocks that got caught up in the meme stock trade that looks like solid long-term investments. And this is especially true now that there&#39;s been a massive correction in many high-growth stocks.</p><p><b>A massive opportunity and a great strategy</b></p><p><b>Offerpad</b>(NYSE:OPAD) is a real estate company that is a so-called iBuyer, or instant buyer, of homes. Offerpad&#39;s core business involves buying homes directly from sellers, doing cosmetic repairs, and then selling them directly to buyers, hopefully earning a profit in the process.</p><p>However, there are a couple of things that set Offerpad apart from its peer group (which really only consists of two other companies). For <a href=\"https://laohu8.com/S/AONE.U\">one</a> thing, Offerpad is the only iBuyer that is more focused on efficiency than all-out growth. Its unit economics have been better than those of its peers, and while it won&#39;t be consistently profitable for some time, it isn&#39;t that far from it right now.</p><p>Second, Offerpad isn&#39;t necessarily trying to completely replace open-market home sales. Its Offerpad Flex product encourages customers to list their home on the open market (with an Offerpad partner agent) and gives them a cash offer to keep in their back pocket in the event they get tired of the traditional sale process.</p><p>Offerpad went a bit meme-stockish after its late 2021 special purpose acquisition company (SPAC) merger was completed, at one point rocketing to nearly $21 from its $10 pre-SPAC valuation. Now that the SPAC boom has cooled, Offerpad has plunged to less than $6, in line with many other recent SPAC targets. But make no mistake -- this is a real business with a huge market opportunity.</p><p><b>Tons of disruptive potential</b></p><p>One of the most discussed stocks in some of the most popular trader chat rooms in 2021, <a href=\"https://laohu8.com/S/SOFI\"><b>SoFi</b></a>, went public through a Chamath Palihapitiya-backed SPAC last year (this was &#34;IPOE&#34; for those who follow Palihapitiya). It started out as a private student loan company but has since evolved into a financial ecosystem, complete with a full lineup of lending products, a credit card, a bank account, a brokerage account, and more. The company also owns the Galileo financial services API and payments platform, which provides functionality for 89 million financial accounts operated by partners.</p><p>To say SoFi&#39;s growth has been phenomenal would be an understatement. Thefintech&#39;suser base has nearly doubled over the past year to more than 2.9 million members, and these users account for roughly 4.3 million different financial products. And it&#39;s on the non-lending side of the business where the growth has been especially impressive, with a 179% year-over-year increase in products as of the third quarter of 2021.</p><p>SoFi has the capability to be a true disruptor of the traditional bank model and is making all the right moves to scale its business in a sustainable way. With shares down 36% in the last two months, now could be a great time to add it at a discount.</p><p><b>The most exciting growth is yet to come</b></p><p>Last but certainly not least, insurance disruptor <a href=\"https://laohu8.com/S/LMND\"><b>Lemonade</b></a> has been a big victim of the recent growth stock headwinds, with shares down by about 35% in the past couple of months and a total of 80% off their all-time high.</p><p>Lemonade is aninsurance technology company, aiming to provide a better way to get insurance quotes, buy policies, and submit claims. In the company&#39;s core business of renters and homeowners insurance, customer feedback has been incredibly strong.</p><p>However, it&#39;s the rollout of Lemonade Car, the company&#39;s much-anticipated auto insurance product -- along with the pending acquisition of <b>Metromile</b>(NASDAQ:MILE)-- where Lemonade could accelerate the availability of the product and rapidly scale the business. If the company can replicate its early insurance success in the auto space, and can keep loss ratios in check, Lemonade could be a big winner for patient investors.</p><p>Remember what you&#39;re buying</p><p>To be sure, these three stocks are real businesses with great long-term growth opportunities. However, it&#39;s important to keep in mind that while the &#34;meme stock&#34; craze has died down, that doesn&#39;t mean it has permanently gone away. And if it comes back, all three of these stocks are likely to experience quite a roller coaster ride. Before you add any of these to your portfolio, it&#39;s important to be prepared for that possibility.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Meme Stocks That Are Actually Solid Long-Term Picks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Meme Stocks That Are Actually Solid Long-Term Picks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-14 19:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/14/3-meme-stocks-that-are-actually-solid-long-term-pi/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, some heavily shorted and some just interesting speculative growth plays, rocketed sharply higher -- ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/14/3-meme-stocks-that-are-actually-solid-long-term-pi/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OPAD":"Offerpad Solutions","LMND":"Lemonade, Inc.","SOFI":"SoFi Technologies Inc.","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2022/01/14/3-meme-stocks-that-are-actually-solid-long-term-pi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144666508","content_text":"The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, some heavily shorted and some just interesting speculative growth plays, rocketed sharply higher -- often doubling, tripling, or more in a very short time. And many took investors on quite a roller coaster ride for months.To be sure, most meme stocks aren't worth buying as long-term investments. For example, it's tough to make a long-term investment case for AMC Entertainment. On the other hand, there are some stocks that got caught up in the meme stock trade that looks like solid long-term investments. And this is especially true now that there's been a massive correction in many high-growth stocks.A massive opportunity and a great strategyOfferpad(NYSE:OPAD) is a real estate company that is a so-called iBuyer, or instant buyer, of homes. Offerpad's core business involves buying homes directly from sellers, doing cosmetic repairs, and then selling them directly to buyers, hopefully earning a profit in the process.However, there are a couple of things that set Offerpad apart from its peer group (which really only consists of two other companies). For one thing, Offerpad is the only iBuyer that is more focused on efficiency than all-out growth. Its unit economics have been better than those of its peers, and while it won't be consistently profitable for some time, it isn't that far from it right now.Second, Offerpad isn't necessarily trying to completely replace open-market home sales. Its Offerpad Flex product encourages customers to list their home on the open market (with an Offerpad partner agent) and gives them a cash offer to keep in their back pocket in the event they get tired of the traditional sale process.Offerpad went a bit meme-stockish after its late 2021 special purpose acquisition company (SPAC) merger was completed, at one point rocketing to nearly $21 from its $10 pre-SPAC valuation. Now that the SPAC boom has cooled, Offerpad has plunged to less than $6, in line with many other recent SPAC targets. But make no mistake -- this is a real business with a huge market opportunity.Tons of disruptive potentialOne of the most discussed stocks in some of the most popular trader chat rooms in 2021, SoFi, went public through a Chamath Palihapitiya-backed SPAC last year (this was \"IPOE\" for those who follow Palihapitiya). It started out as a private student loan company but has since evolved into a financial ecosystem, complete with a full lineup of lending products, a credit card, a bank account, a brokerage account, and more. The company also owns the Galileo financial services API and payments platform, which provides functionality for 89 million financial accounts operated by partners.To say SoFi's growth has been phenomenal would be an understatement. Thefintech'suser base has nearly doubled over the past year to more than 2.9 million members, and these users account for roughly 4.3 million different financial products. And it's on the non-lending side of the business where the growth has been especially impressive, with a 179% year-over-year increase in products as of the third quarter of 2021.SoFi has the capability to be a true disruptor of the traditional bank model and is making all the right moves to scale its business in a sustainable way. With shares down 36% in the last two months, now could be a great time to add it at a discount.The most exciting growth is yet to comeLast but certainly not least, insurance disruptor Lemonade has been a big victim of the recent growth stock headwinds, with shares down by about 35% in the past couple of months and a total of 80% off their all-time high.Lemonade is aninsurance technology company, aiming to provide a better way to get insurance quotes, buy policies, and submit claims. In the company's core business of renters and homeowners insurance, customer feedback has been incredibly strong.However, it's the rollout of Lemonade Car, the company's much-anticipated auto insurance product -- along with the pending acquisition of Metromile(NASDAQ:MILE)-- where Lemonade could accelerate the availability of the product and rapidly scale the business. If the company can replicate its early insurance success in the auto space, and can keep loss ratios in check, Lemonade could be a big winner for patient investors.Remember what you're buyingTo be sure, these three stocks are real businesses with great long-term growth opportunities. However, it's important to keep in mind that while the \"meme stock\" craze has died down, that doesn't mean it has permanently gone away. And if it comes back, all three of these stocks are likely to experience quite a roller coaster ride. Before you add any of these to your portfolio, it's important to be prepared for that possibility.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1024,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607004893,"gmtCreate":1639452342052,"gmtModify":1639452342206,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607004893","repostId":"1174096078","repostType":4,"repost":{"id":"1174096078","kind":"news","pubTimestamp":1639450379,"share":"https://www.laohu8.com/m/news/1174096078?lang=&edition=full","pubTime":"2021-12-14 10:52","market":"us","language":"en","title":"These 5 stocks are driving the market","url":"https://stock-news.laohu8.com/highlight/detail?id=1174096078","media":"CNN Business","summary":"London (CNN Business) - Despiteanxiety about inflationand theOmicron variant, the stock market is on","content":"<p><b>London (CNN Business)</b>&nbsp;-&nbsp;Despiteanxiety about inflationand theOmicron variant, the stock market is on track for another banner year. That's in large part thanks to stellar gains from just a handful of stocks.</p>\n<p>What's happening: According to new research from Goldman Sachs, just five companies —Microsoft,Apple,Nvidia,Tesla&nbsp;and Google parent&nbsp;Alphabet&nbsp;— have contributed 51% of S&amp;P 500 returns since April. Going back to the beginning of the year, they account for more than a third of the index's rise.</p>\n<p>We've&nbsp;spilled plenty of ink&nbsp;talking about the clout of FAANG stocks —&nbsp;Facebook, Apple,Amazon,Netflix&nbsp;and Google. But is it time to retire FAANG and ring in the era of ... MANTA?</p>\n<p><img src=\"https://static.tigerbbs.com/54f62ca486902385551327c22d6e6c76\" tg-width=\"1200\" tg-height=\"736\" width=\"100%\" height=\"auto\"></p>\n<p>After shooting up 76% in 2020, Amazon's stock is up just 6% this year, compared to a nearly 26% rise in the S&amp;P 500. Supply chain problems and pay hikes to recruit and retain workers have eaten into Amazon's profits despite the ongoing boom in online shopping.</p>\n<p>Netflix's stock has also lost steam, rising 13% this year after skyrocketing 67% in 2020. The company has scored big with shows like \"Squid Game,\" but investors are worried about whether the company can&nbsp;keep rapidly recruiting subscribers&nbsp;as competition among streaming services grows.</p>\n<p>Facebook, now called Meta, has done slightly better, jumping 21% year-to-date. But that leaves it on track for its worst year since 2018, as investors weigh regulatory threats and the social network's pivot to virtual reality.</p>\n<p>Shares in Apple and Google have popped 35% and 69%, respectively. That's good enough to join the MANTA club.</p>\n<p>Tesla also makes the cut. After rising an eye-popping 743% in 2020, shares of Elon Musk's electric carmaker have kept pushing higher. They're up 44% since the beginning of 2021 as Wall Street tries to position itself for the green energy transition.</p>\n<p>Chipmaker Nvidia, for its part, has shaken off global supply issues and matched 122% gains last year with a 131% increase in 2021. Microsoft's surging cloud business has driven a 54% stock jump this year, also beating its performance in 2020.</p>\n<p>Step back: There have been moments over the past 12 months when investors have tried to reduce their exposure to high-growth companies, which don't look as attractive in a world where interest rates could begin to rise. But on the whole, tech and Tesla have remained the&nbsp;undisputed market champions&nbsp;— even if the basket of winners looks slightly different.</p>\n<p>A question that often arises when looking at the small number of companies that power the S&amp;P 500 is whether the concentration makes the market vulnerable to a larger pullback. If something happens to Nvidia, for example, will everyone get hurt — whether they own stock in the company or not?</p>\n<p>Goldman Sachs thinks that as it stands, the risk is low. The investment bank said investors have already priced in the beginning of interest rate hikes by the Federal Reserve and notes that borrowing costs will remain extremely low. Corporate earnings also \"continue to surpass expectations.\"</p>\n<p>\"While 'unknown unknowns' cause the largest drawdowns and by their nature are impossible to assess in advance, the macro environment does not suggest drawdown risk is elevated in the coming months,\" its strategists said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 5 stocks are driving the market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 5 stocks are driving the market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 10:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/12/13/investing/premarket-stocks-trading/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>London (CNN Business) - Despiteanxiety about inflationand theOmicron variant, the stock market is on track for another banner year. That's in large part thanks to stellar gains from just a handful of ...</p>\n\n<a href=\"https://edition.cnn.com/2021/12/13/investing/premarket-stocks-trading/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软","NVDA":"英伟达","AAPL":"苹果","TSLA":"特斯拉","GOOGL":"谷歌A","NFLX":"奈飞","AMZN":"亚马逊"},"source_url":"https://edition.cnn.com/2021/12/13/investing/premarket-stocks-trading/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174096078","content_text":"London (CNN Business) - Despiteanxiety about inflationand theOmicron variant, the stock market is on track for another banner year. That's in large part thanks to stellar gains from just a handful of stocks.\nWhat's happening: According to new research from Goldman Sachs, just five companies —Microsoft,Apple,Nvidia,Tesla and Google parent Alphabet — have contributed 51% of S&P 500 returns since April. Going back to the beginning of the year, they account for more than a third of the index's rise.\nWe've spilled plenty of ink talking about the clout of FAANG stocks — Facebook, Apple,Amazon,Netflix and Google. But is it time to retire FAANG and ring in the era of ... MANTA?\n\nAfter shooting up 76% in 2020, Amazon's stock is up just 6% this year, compared to a nearly 26% rise in the S&P 500. Supply chain problems and pay hikes to recruit and retain workers have eaten into Amazon's profits despite the ongoing boom in online shopping.\nNetflix's stock has also lost steam, rising 13% this year after skyrocketing 67% in 2020. The company has scored big with shows like \"Squid Game,\" but investors are worried about whether the company can keep rapidly recruiting subscribers as competition among streaming services grows.\nFacebook, now called Meta, has done slightly better, jumping 21% year-to-date. But that leaves it on track for its worst year since 2018, as investors weigh regulatory threats and the social network's pivot to virtual reality.\nShares in Apple and Google have popped 35% and 69%, respectively. That's good enough to join the MANTA club.\nTesla also makes the cut. After rising an eye-popping 743% in 2020, shares of Elon Musk's electric carmaker have kept pushing higher. They're up 44% since the beginning of 2021 as Wall Street tries to position itself for the green energy transition.\nChipmaker Nvidia, for its part, has shaken off global supply issues and matched 122% gains last year with a 131% increase in 2021. Microsoft's surging cloud business has driven a 54% stock jump this year, also beating its performance in 2020.\nStep back: There have been moments over the past 12 months when investors have tried to reduce their exposure to high-growth companies, which don't look as attractive in a world where interest rates could begin to rise. But on the whole, tech and Tesla have remained the undisputed market champions — even if the basket of winners looks slightly different.\nA question that often arises when looking at the small number of companies that power the S&P 500 is whether the concentration makes the market vulnerable to a larger pullback. If something happens to Nvidia, for example, will everyone get hurt — whether they own stock in the company or not?\nGoldman Sachs thinks that as it stands, the risk is low. The investment bank said investors have already priced in the beginning of interest rate hikes by the Federal Reserve and notes that borrowing costs will remain extremely low. Corporate earnings also \"continue to surpass expectations.\"\n\"While 'unknown unknowns' cause the largest drawdowns and by their nature are impossible to assess in advance, the macro environment does not suggest drawdown risk is elevated in the coming months,\" its strategists said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":478,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":114059740,"gmtCreate":1623037757780,"gmtModify":1631883954563,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Best","listText":"Best","text":"Best","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/114059740","repostId":"2141282721","repostType":4,"repost":{"id":"2141282721","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623034890,"share":"https://www.laohu8.com/m/news/2141282721?lang=&edition=full","pubTime":"2021-06-07 11:01","market":"hk","language":"en","title":"China's May exports rise 27.9% y/y, imports +51.1% y/y","url":"https://stock-news.laohu8.com/highlight/detail?id=2141282721","media":"Reuters","summary":"BEIJING, June 7 (Reuters) - China's exports rose 27.9% in May from a year earlier, missing forecasts","content":"<p>BEIJING, June 7 (Reuters) - China's exports rose 27.9% in May from a year earlier, missing forecasts, while imports increased 51.1%, customs data showed on Monday, as the world's second-largest economy continued its recovery from last year's pandemic slump.</p><p>Analysts in a Reuters poll of economists had forecast exports would jump 32.1% from year earlier and for imports to rise 51.5%.</p><p>China posted a trade surplus of $45.53 billion in May, compared with the poll's forecast for a $50.5 Billion surplus and widening from $42.86 billion surplus in April.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's May exports rise 27.9% y/y, imports +51.1% y/y</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's May exports rise 27.9% y/y, imports +51.1% y/y\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-07 11:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, June 7 (Reuters) - China's exports rose 27.9% in May from a year earlier, missing forecasts, while imports increased 51.1%, customs data showed on Monday, as the world's second-largest economy continued its recovery from last year's pandemic slump.</p><p>Analysts in a Reuters poll of economists had forecast exports would jump 32.1% from year earlier and for imports to rise 51.5%.</p><p>China posted a trade surplus of $45.53 billion in May, compared with the poll's forecast for a $50.5 Billion surplus and widening from $42.86 billion surplus in April.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2141282721","content_text":"BEIJING, June 7 (Reuters) - China's exports rose 27.9% in May from a year earlier, missing forecasts, while imports increased 51.1%, customs data showed on Monday, as the world's second-largest economy continued its recovery from last year's pandemic slump.Analysts in a Reuters poll of economists had forecast exports would jump 32.1% from year earlier and for imports to rise 51.5%.China posted a trade surplus of $45.53 billion in May, compared with the poll's forecast for a $50.5 Billion surplus and widening from $42.86 billion surplus in April.","news_type":1},"isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":693947302,"gmtCreate":1639965038003,"gmtModify":1639965417989,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693947302","repostId":"2192096049","repostType":4,"repost":{"id":"2192096049","kind":"highlight","pubTimestamp":1639963835,"share":"https://www.laohu8.com/m/news/2192096049?lang=&edition=full","pubTime":"2021-12-20 09:30","market":"us","language":"en","title":"3 Best Vacation Stocks To Watch In December","url":"https://stock-news.laohu8.com/highlight/detail?id=2192096049","media":"Motley Fool","summary":"These three stocks should be turbocharged leaders in a beaten-down sector.","content":"<p>Even after the economy reopened from the pandemic, the travel and tourism industry is still touch and go as consumers ease back into more normal routines. Any news about new coronavirus variants can send stocks skidding on fears it will derail any momentum they've built.</p>\n<p>While it's premature to give the all-clear signal, there's good reason to think 2022 and beyond will provide much better opportunities for the industry. The following trio of companies represent some of the best chances to capitalize on an industry that is still beaten down but ready to rise.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e3ea498aa9acea4ae2d9123ed790db5d\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Norwegian Cruise Lines</h2>\n<p>The cruise industry was arguably the hardest hit by the pandemic because ships were forbidden from sailing well after the rest of the economy had reopened. And when ships were allowed back to sea, it was at a greatly reduced capacity than beforehand.</p>\n<p>To survive the crisis, cruise ship operators had to take on massive amounts of debt. <b>Norwegian Cruise Line</b> (NYSE:NCLH) saw its long-term debt balloon from $6.8 billion to over $11.7 billion at the end of 2020, and its financial report last month showed it had more than $12.4 billion worth at the end of September. It recently said it was going to be adding nearly another billion dollars to the total.</p>\n<p>While it might not be smooth sailing, Norwegian is looking better than it has, even before the pandemic. Some 40% of its total capacity is back in the water, representing 11 ships across the Norwegian, Oceania, and Regent Seven Seas brands. It also notes its cumulative booked position for 2022 is in line with what it experienced in 2019, which was a record year for the cruise line. And it's achieving the elevated bookings at higher prices, even when taking into account the impact of the credits it is giving to passengers for cruises that were canceled during the pandemic.</p>\n<p>Although Norwegian's stock is down 64% from where it was before the crisis, it's more than doubled from the lows it struck in the immediate aftermath. With Wall Street expecting the cruise ship to reach parity with 2019 revenue next year and then grow 35% over the next two years, Norwegian Cruise Lines looks like a ship-shape investment.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/96a3f1a8207dea2015ed644124656e54\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Disney</h2>\n<p>Being diversified is usually a sign of strength in that it offers protection in a downturn. But it was no shield for <b>Disney</b> (NYSE:DIS), which saw virtually all of its operations impacted by the near-complete shutdown of almost all global economies.</p>\n<p>Its theme parks were closed, theaters went dark, and stores were closed, leading advertising to plummet because consumers weren't shopping. And yes, its cruise ships were forbidden to sail too.</p>\n<p>The <a href=\"https://laohu8.com/S/AONE.U\">one</a> bright spot was Disney+, the streaming service launched just prior to the pandemic, which went on to break all kinds of subscriber- number records as people forced to stay home signed up in droves.</p>\n<p>While it still labors under COVID-related restrictions that impede a full recovery, that's going to change. As the crisis recedes further in the rearview mirror, the synergies of its far-flung operations that make Disney a juggernaut will be on full display once more.</p>\n<p>Disney's theme parks are profitable once again, it's making movies once more, and its other media components are back on track. As characters inspire toys, theme park rides, and spinoff TV shows, the power of the Disney brand will return to the fore.</p>\n<p>Disney's stock is down 18% in 2021, but the revenue engines are expected to spring to life, nearly doubling to $122 billion in five years, leading profits to triple. It's a destination for investors looking to capitalize on a recovery.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/614d7000a7483cacd563eb584947ca31\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Airbnb</h2>\n<p><b>Airbnb</b> (NASDAQ:ABNB) has a simple business model of connecting people who want to get away for short-term vacations with people who have accommodations they're willing to rent out. Its stays tend to be cheaper and more convenient than those at traditional hotels, and its recent results show the pandemic did not permanently dent consumer demand for these rentals.</p>\n<p>Travel began to recover in earnest earlier this year, allowing Airbnb to post a record third quarter, with 1 billion guest arrivals worldwide. It ended 2020 with about 5.6 million listings and the number of active listings has grown every quarter this year. And there is plenty of room to grow still.</p>\n<p>While there are more than 130 million households in the U.S., there are as many as 1 billion globally, and since short-term travel accommodations in a residence is still an industry in its infancy, Airbnb has the branding to capture an even greater share of the market.</p>\n<p>And now Airbnb is getting into longer-stay rentals too, which provides a whole new avenue for growth.</p>\n<p>Analysts expect revenue to grow from $5.9 billion this year to over $13.6 billion in 2025, good for a 23% compounded annual growth rate. Although the market has priced a lot of this opportunity into the stock, shares are down 25% from their recent highs even as management expects growth to accelerate in the fourth quarter.</p>\n<p>Its asset-lite business model keeps its overhead low and profit margins high, and Airbnb is a travel-and-tourism stock investors will want to check into.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Vacation Stocks To Watch In December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Vacation Stocks To Watch In December\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 09:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/19/3-best-vacation-stocks-to-watch-in-december/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even after the economy reopened from the pandemic, the travel and tourism industry is still touch and go as consumers ease back into more normal routines. Any news about new coronavirus variants can ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/19/3-best-vacation-stocks-to-watch-in-december/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼","ABNB":"爱彼迎","NCLH":"挪威邮轮"},"source_url":"https://www.fool.com/investing/2021/12/19/3-best-vacation-stocks-to-watch-in-december/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192096049","content_text":"Even after the economy reopened from the pandemic, the travel and tourism industry is still touch and go as consumers ease back into more normal routines. Any news about new coronavirus variants can send stocks skidding on fears it will derail any momentum they've built.\nWhile it's premature to give the all-clear signal, there's good reason to think 2022 and beyond will provide much better opportunities for the industry. The following trio of companies represent some of the best chances to capitalize on an industry that is still beaten down but ready to rise.\nImage source: Getty Images.\nNorwegian Cruise Lines\nThe cruise industry was arguably the hardest hit by the pandemic because ships were forbidden from sailing well after the rest of the economy had reopened. And when ships were allowed back to sea, it was at a greatly reduced capacity than beforehand.\nTo survive the crisis, cruise ship operators had to take on massive amounts of debt. Norwegian Cruise Line (NYSE:NCLH) saw its long-term debt balloon from $6.8 billion to over $11.7 billion at the end of 2020, and its financial report last month showed it had more than $12.4 billion worth at the end of September. It recently said it was going to be adding nearly another billion dollars to the total.\nWhile it might not be smooth sailing, Norwegian is looking better than it has, even before the pandemic. Some 40% of its total capacity is back in the water, representing 11 ships across the Norwegian, Oceania, and Regent Seven Seas brands. It also notes its cumulative booked position for 2022 is in line with what it experienced in 2019, which was a record year for the cruise line. And it's achieving the elevated bookings at higher prices, even when taking into account the impact of the credits it is giving to passengers for cruises that were canceled during the pandemic.\nAlthough Norwegian's stock is down 64% from where it was before the crisis, it's more than doubled from the lows it struck in the immediate aftermath. With Wall Street expecting the cruise ship to reach parity with 2019 revenue next year and then grow 35% over the next two years, Norwegian Cruise Lines looks like a ship-shape investment.\nImage source: Getty Images.\nDisney\nBeing diversified is usually a sign of strength in that it offers protection in a downturn. But it was no shield for Disney (NYSE:DIS), which saw virtually all of its operations impacted by the near-complete shutdown of almost all global economies.\nIts theme parks were closed, theaters went dark, and stores were closed, leading advertising to plummet because consumers weren't shopping. And yes, its cruise ships were forbidden to sail too.\nThe one bright spot was Disney+, the streaming service launched just prior to the pandemic, which went on to break all kinds of subscriber- number records as people forced to stay home signed up in droves.\nWhile it still labors under COVID-related restrictions that impede a full recovery, that's going to change. As the crisis recedes further in the rearview mirror, the synergies of its far-flung operations that make Disney a juggernaut will be on full display once more.\nDisney's theme parks are profitable once again, it's making movies once more, and its other media components are back on track. As characters inspire toys, theme park rides, and spinoff TV shows, the power of the Disney brand will return to the fore.\nDisney's stock is down 18% in 2021, but the revenue engines are expected to spring to life, nearly doubling to $122 billion in five years, leading profits to triple. It's a destination for investors looking to capitalize on a recovery.\nImage source: Getty Images.\nAirbnb\nAirbnb (NASDAQ:ABNB) has a simple business model of connecting people who want to get away for short-term vacations with people who have accommodations they're willing to rent out. Its stays tend to be cheaper and more convenient than those at traditional hotels, and its recent results show the pandemic did not permanently dent consumer demand for these rentals.\nTravel began to recover in earnest earlier this year, allowing Airbnb to post a record third quarter, with 1 billion guest arrivals worldwide. It ended 2020 with about 5.6 million listings and the number of active listings has grown every quarter this year. And there is plenty of room to grow still.\nWhile there are more than 130 million households in the U.S., there are as many as 1 billion globally, and since short-term travel accommodations in a residence is still an industry in its infancy, Airbnb has the branding to capture an even greater share of the market.\nAnd now Airbnb is getting into longer-stay rentals too, which provides a whole new avenue for growth.\nAnalysts expect revenue to grow from $5.9 billion this year to over $13.6 billion in 2025, good for a 23% compounded annual growth rate. Although the market has priced a lot of this opportunity into the stock, shares are down 25% from their recent highs even as management expects growth to accelerate in the fourth quarter.\nIts asset-lite business model keeps its overhead low and profit margins high, and Airbnb is a travel-and-tourism stock investors will want to check into.","news_type":1},"isVote":1,"tweetType":1,"viewCount":966,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699757555,"gmtCreate":1639909859095,"gmtModify":1639909859267,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699757555","repostId":"2192976991","repostType":4,"repost":{"id":"2192976991","kind":"news","pubTimestamp":1639880228,"share":"https://www.laohu8.com/m/news/2192976991?lang=&edition=full","pubTime":"2021-12-19 10:17","market":"us","language":"en","title":"5 Top-Ranked Dividend Growth Stocks for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192976991","media":"Zacks","summary":"As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend","content":"<p>As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend investing seems to be a better bet. Though it does not offer dramatic price appreciation, the strategy is a major source of consistent income for investors to create wealth when returns from the equity market are at risk.</p>\n<p>Stocks with a strong history of year-over-year dividend growth form a healthy portfolio with a greater scope of capital appreciation as opposed to simple dividend-paying stocks or those that have high yields. We have selected five dividend growth stocks — <b><a href=\"https://laohu8.com/S/BCC\">Boise Cascade L.L.C.</a></b> BCC, <b>J.B. Hunt Transport Services</b> JBHT, <b>Lowe's Companies</b> LOW, <b>Broadcom Inc. </b>AVGO and <b>Carriage Services</b> CSV — that could be compelling picks for your portfolio.</p>\n<h4><b>Why Dividend Growth?</b></h4>\n<p>Stocks that have a strong history of dividend growth belong to mature companies, which are less susceptible to large swings in the market, and thus act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, these offer downside protection with their consistent increase in payouts.</p>\n<p>Additionally, these stocks have superior fundamentals that make dividend growth a quality and promising investment for the long term. These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. Further, a history of strong dividend growth indicates that dividend increase is likely in the future.</p>\n<p>Moreover, a history of dividend growth year over year leads to a healthy portfolio with a greater scope of capital appreciation than simple dividend-paying stocks or those with high yields. Although these stocks do not necessarily have the highest yields, they have outperformed for a longer period than the broader stock market or any other dividend-paying stock.</p>\n<p>As a result, picking dividend growth stocks appears as a winning strategy when some other parameters are also included.</p>\n<p><b>5-Year Historical Dividend Growth greater than zero</b>: This selects stocks with a solid dividend growth history.</p>\n<p><b>5-Year Historical Sales Growth greater than zero</b>: This represents stocks with a strong record of growing revenues.</p>\n<p><b>5-Year Historical EPS Growth greater than zero</b>: This represents stocks with a solid earnings growth history.</p>\n<p><b>Next 3-5 Year EPS Growth Rate greater than zero</b>: This represents the rate at which a company’s earnings are expected to grow. Improving earnings should help companies sustain dividend payments.</p>\n<p><b>Price/Cash Flow less than M-Industry</b>: A ratio less than M-industry indicates that the stock is undervalued in that industry and that an investor needs to pay less for better cash flow generated by the company.</p>\n<p><b>52-Week Price Change greater than S&amp;P 500 (Market Weight)</b>: This ensures that the stock appreciated more than the S&amp;P 500 over the past year.</p>\n<p><b>Top Zacks Rank</b>: Stocks having a Zacks Rank #1 (Strong Buy) and 2 (Buy) generally outperform their peers in all types of market environments.</p>\n<p><b>Growth Score of B or better</b>: Our research shows that stocks with a Growth Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.</p>\n<p>Just these few criteria narrowed down the universe from over 7,700 stocks to just 16.</p>\n<p>Here are five of the 16 stocks that fit the bill:</p>\n<p>Idaho-based <b>Boise Cascade</b> operates as a wood products manufacturer and building materials distributor. It has seen solid earnings estimate revision of 13 cents for this year over the past month and has an estimated earnings growth rate of 159%.</p>\n<p>Boise Cascade has a Zacks Rank #1 and Growth Score of A. You can see <b>the complete list of today’s Zacks #1 Rank stocks here</b>.</p>\n<p>Arkansas-based <b>J.B. Hunt Transport </b>is a provider of a broad range of transportation services to a diverse group of customers through the United States, Canada and Mexico. JBHT has an estimated earnings growth rate of 44.5% for this year and delivered an average earnings surprise of 9.89% for the past four quarters.</p>\n<p>J.B. Hunt has a Zacks Rank #2 and Growth Score of A.</p>\n<p>North Carolina-based <b>Lowe's</b> has evolved as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the world’s leading home improvement retailers offering services to homeowners, renters and commercial business customers. LOW saw solid earnings estimate revision of 54 cents over the past 30 days for the fiscal year (ending January 2022) and has an expected earnings growth rate of 34.4%.</p>\n<p>Lowe’s has a Zacks Rank #2 and Growth Score of B.</p>\n<p>California-based <b>Broadcom</b> is a premier designer, developer and global supplier of a broad range of semiconductor devices with a focus on complex digital and mixed-signal complementary metal oxide semiconductor based devices and analog III-V based products. The stock saw a solid earnings estimate revision of $2.01 for the fiscal year (ending October 2022) over the past 30 days and has an expected earnings growth rate of 17.9%.</p>\n<p>Broadcom has a Zacks Rank #2 and Growth Score of B.</p>\n<p>Texas-based <b>Carriage Services</b> is a leading provider of death care services and products in the United States. CSV delivered an average earnings surprise of 27.96% for the past four quarters and has an expected earnings growth rate of 64%.</p>\n<p>Carriage Services carries a Zacks Rank #2 and has a Growth Score of B.</p>\n<p>You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.</p>\n<p>The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top-Ranked Dividend Growth Stocks for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top-Ranked Dividend Growth Stocks for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/5-top-ranked-dividend-growth-133601757.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend investing seems to be a better bet. Though it does not offer dramatic price appreciation, the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/5-top-ranked-dividend-growth-133601757.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AVGOP":"BROADCOM INC PFD SER A 22","BCC":"Boise Cascade L.L.C.","AVGO":"博通","CSV":"Carriage Services Inc","BK4504":"桥水持仓","BK4512":"苹果概念","BK4566":"资本集团","BK4192":"特殊消费者服务","BK4515":"5G概念","JBHT":"JB Hunt运输服务","BK4083":"家庭装潢零售","LOW":"劳氏","BK4520":"美国基建股","BK4022":"陆运","BK4104":"贸易公司与经销商"},"source_url":"https://finance.yahoo.com/news/5-top-ranked-dividend-growth-133601757.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2192976991","content_text":"As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend investing seems to be a better bet. Though it does not offer dramatic price appreciation, the strategy is a major source of consistent income for investors to create wealth when returns from the equity market are at risk.\nStocks with a strong history of year-over-year dividend growth form a healthy portfolio with a greater scope of capital appreciation as opposed to simple dividend-paying stocks or those that have high yields. We have selected five dividend growth stocks — Boise Cascade L.L.C. BCC, J.B. Hunt Transport Services JBHT, Lowe's Companies LOW, Broadcom Inc. AVGO and Carriage Services CSV — that could be compelling picks for your portfolio.\nWhy Dividend Growth?\nStocks that have a strong history of dividend growth belong to mature companies, which are less susceptible to large swings in the market, and thus act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, these offer downside protection with their consistent increase in payouts.\nAdditionally, these stocks have superior fundamentals that make dividend growth a quality and promising investment for the long term. These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. Further, a history of strong dividend growth indicates that dividend increase is likely in the future.\nMoreover, a history of dividend growth year over year leads to a healthy portfolio with a greater scope of capital appreciation than simple dividend-paying stocks or those with high yields. Although these stocks do not necessarily have the highest yields, they have outperformed for a longer period than the broader stock market or any other dividend-paying stock.\nAs a result, picking dividend growth stocks appears as a winning strategy when some other parameters are also included.\n5-Year Historical Dividend Growth greater than zero: This selects stocks with a solid dividend growth history.\n5-Year Historical Sales Growth greater than zero: This represents stocks with a strong record of growing revenues.\n5-Year Historical EPS Growth greater than zero: This represents stocks with a solid earnings growth history.\nNext 3-5 Year EPS Growth Rate greater than zero: This represents the rate at which a company’s earnings are expected to grow. Improving earnings should help companies sustain dividend payments.\nPrice/Cash Flow less than M-Industry: A ratio less than M-industry indicates that the stock is undervalued in that industry and that an investor needs to pay less for better cash flow generated by the company.\n52-Week Price Change greater than S&P 500 (Market Weight): This ensures that the stock appreciated more than the S&P 500 over the past year.\nTop Zacks Rank: Stocks having a Zacks Rank #1 (Strong Buy) and 2 (Buy) generally outperform their peers in all types of market environments.\nGrowth Score of B or better: Our research shows that stocks with a Growth Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.\nJust these few criteria narrowed down the universe from over 7,700 stocks to just 16.\nHere are five of the 16 stocks that fit the bill:\nIdaho-based Boise Cascade operates as a wood products manufacturer and building materials distributor. It has seen solid earnings estimate revision of 13 cents for this year over the past month and has an estimated earnings growth rate of 159%.\nBoise Cascade has a Zacks Rank #1 and Growth Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.\nArkansas-based J.B. Hunt Transport is a provider of a broad range of transportation services to a diverse group of customers through the United States, Canada and Mexico. JBHT has an estimated earnings growth rate of 44.5% for this year and delivered an average earnings surprise of 9.89% for the past four quarters.\nJ.B. Hunt has a Zacks Rank #2 and Growth Score of A.\nNorth Carolina-based Lowe's has evolved as one of the world’s leading home improvement retailers offering services to homeowners, renters and commercial business customers. LOW saw solid earnings estimate revision of 54 cents over the past 30 days for the fiscal year (ending January 2022) and has an expected earnings growth rate of 34.4%.\nLowe’s has a Zacks Rank #2 and Growth Score of B.\nCalifornia-based Broadcom is a premier designer, developer and global supplier of a broad range of semiconductor devices with a focus on complex digital and mixed-signal complementary metal oxide semiconductor based devices and analog III-V based products. The stock saw a solid earnings estimate revision of $2.01 for the fiscal year (ending October 2022) over the past 30 days and has an expected earnings growth rate of 17.9%.\nBroadcom has a Zacks Rank #2 and Growth Score of B.\nTexas-based Carriage Services is a leading provider of death care services and products in the United States. CSV delivered an average earnings surprise of 27.96% for the past four quarters and has an expected earnings growth rate of 64%.\nCarriage Services carries a Zacks Rank #2 and has a Growth Score of B.\nYou can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.\nThe Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.","news_type":1},"isVote":1,"tweetType":1,"viewCount":922,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699518088,"gmtCreate":1639837572679,"gmtModify":1639837572876,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699518088","repostId":"1189235922","repostType":4,"repost":{"id":"1189235922","kind":"news","pubTimestamp":1639809269,"share":"https://www.laohu8.com/m/news/1189235922?lang=&edition=full","pubTime":"2021-12-18 14:34","market":"us","language":"en","title":"DaVita authorizes additional $2B share repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1189235922","media":"Seeking Alpha","summary":"DaVita  Board of Directors increased the authorization under the existing share repurchase program b","content":"<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p>\n<p>The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p>\n<p>Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DaVita authorizes additional $2B share repurchase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita authorizes additional $2B share repurchase\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 14:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DaVita  Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.\nThe amount of shares authorized to be repurchased under ...</p>\n\n<a href=\"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DVA":"达维塔保健"},"source_url":"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189235922","content_text":"DaVita  Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.\nThe amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .\nSome bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'","news_type":1},"isVote":1,"tweetType":1,"viewCount":1142,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}